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SUMMARY
Diagnostic ultrasound was introduced into obstetrics by 
Donald in the late 1950's and since that time has played 
an increasingly important role in the characterisation of 
normal fetal growth and the detection of intrauterine 
growth retardation. As a group intrauterine growth 
retarded fetuses have a high incidence of perinatal 
mortality and morbidity, and, in the long term, a higher 
incidence of neurological and intellectual impairment. 
Therefore, the antenatal detection of this group is 
desirable to permit careful monitoring and delivery at the 
optimal time, under the optimal circumstances.
The objectives of this thesis were therefore to study the 
role of obstetric ultrasound in: (1) the determination of
birthweight for gestational age growth standards which 
were displayed for all women with singleton live births, 
attending The Queen Mother's Hospital (QMH) antenatal 
clinic from 1985 to 1987; (2) the detection of
intrauterine growth retardation (IUGR) by evaluating the 
effectiveness of seven single ultrasound measurements and 
two of their combinations . The association of fetal 
growth retardation with perinatal mortality and congenital 
malformation was also studied.
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In pursuit of the first objective a sample of 10259 births 
occurring in The QMH from 1985 to 1987 were analysed. 
Tables and curves were provided showing the means, 
standard deviations and 5th, 10th, 25th, 50th, 75th, 90th
and 95th centiles of birthweight by gestational age for 
each week of gestation from 28 to 42 weeks. Tables and 
curves were classified according to the sex of the infant 
and parity of the mother. The sample was composed of 
singleton live infants born to women who had ultrasound 
dating of gestation prior to 20 weeks. This sample 
comprised 26% of all live birth in Greater Glasgow Health 
Board area and 5.2% of all live births in Scotland during 
the study period. Similar analysis was repeated on a 
subset of 3919 births selected from the above sample. 
Women included in this group had to meet a number of 
criteria in order to minimize the effect they might have 
on the distribution of birthweight for gestational age. 
These criteria were: (1) their babies were without
congenital malformation; (2) spontaneous onset of labour; 
(3) not on the contraceptive pill for the three months 
before pregnancy; (4) certain date of last menstrual 
period; (5) gestational age confirmed by ultrasound prior 
to 20 weeks. The QMH based standards were then compared 
with a number of growth standards reported for other 
populations, including the widely adopted standards of 
Thomson and associates (1968) for Aberdeen 1948-64 and
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Forbes and Smalls (1982) for Scotland 1975-79. The QMH 
based standards were comparable to the previous Scottish 
standards and slightly higher later in pregnancy. 
Similarly the 10th centile values were comparable with 
Scotland 1975-79 (Forbes & Smalls, 1982), but beyond 38 
weeks of gestation they were significantly higher.
In contrast to previous growth standards, the QMH based 
standards were obtained from a group of women with 
accurate ultrasound dating early in pregnancy. These 
results would justify a further study based on a large 
population to establish a proper growth standard. 
Nevertheless, tables and curves will be a useful guide for 
the birthweigh monitoring of infants born in the QMH.
Other variables such as sex of the infant and parity of 
the mother were also examined in relation to birthweight. 
Male infants were heavier than females and infants of 
multiparae were heavier than infants of primiparae.
In pursuing the second objective, a total of 14791 
consecutive ultrasound measurements of 2810 women with 
singleton pregnancies, were analysed. All pregnancies were 
dated before the 20th week by ultrasonic measurements and 
had a second ultrasonic examination between 28 and 36
- 14 -
weeks of gestation to permit measurements of 7 single 
measurements and 2 of their combinations to detect those 
fetuses whose birthweights were below the 10th centile 
line on the Scottish standards 1975-79 (Forbes & Smalls, 
1982). The measurements of biparietal diameter (BPD), 
head area (HA), head circumference (HC) , abdominal area 
(AA), abdominal circumference (AC) femur length (FL), 
amniotic fluid volume (LV), abdominal area x femur length 
(AAFL) and abdominal circumference x femur length (ACFL) 
were studied. The measurements below the 10th centile for 
gestational age were considered abnormal. Fetal head 
measurements had inferior predictive ability than 
abdominal measurements. The LV and FL measurements proved 
to be the least sensitive indicators of IUGR. The 
combination of FL measurement with that of abdomen had 
markedly improved the diagnostic accuracy over that of 
single measurement of FL, AA or AC. Also, the accuracy of 
the predictions of all measurements improved greatly when 
scans were performed within one week of delivery. The 
AAFL measurement was the most predictive of IUGR as it had 
the highest sensitivity, specificity and predictive value 
of positive and negative test rate, and lowest 'false- 
negative' rate. Despite a 'false-positive' rate of 24%, 
AAFL is more useful than the AA measurement, as it had a 
minimal average cost on the basis of the assumption that, 
in clinical term, the cost of 'false-negative' result is
- 15 -
result is much higher than the 'false-positive* result. 
AAFL measurement is an advantage as part of a standard 
obstetrical ultrasound examination for the assessment of 
fetal growth in the second and third trimester. 
Furthermore, calculation of the AAFL measurement by a 
single examination around 34 weeks of gestation is 
practically simple. Combined with accurate ultrasound 
dating of gestational age early in pregnancy, the high 
sensitivity and predictive value of a negative test is an 
advantage as a screening procedure for the detection of 
IUGR.
There was an association of IUGR with perinatal mortality 
and fetal malformation. Infants of birthweight less than 
5th centile for gestational age were at a greater risk of 
perinatal death than those whose birthweight lay between 
the 5th and 9th centiles.
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1. INTRODUCTION
1.1 General Introduction to Ultrasound
1.1.1 Development of clinical applications
The first practical application of an ultrasonic imaging 
technique was in depth determination and submarine 
detection during World War 1. Improvement and
miniaturisation of transducers led Firestone in 1945 to 
apply pulsed ultrasound to the detection of flaws in 
metal. From this use arose the idea of applying the 
imaging technique to clinical medicine, specifically to 
the study of soft tissue. The pioneer work in ultrasound 
as a medical tool was carried out by two workers in 
different centres, namely Donald and associates (1958) in 
Glasgow and Holmes and Howry (1963) in Denver, who both 
saw the medical potential of ultrasonic imaging and 
applied it to obstetrics and gynaecology. They introduced 
techniques and equipment which, with further development 
over a period of thirty years, have revolutionised the 
practice of obstetrics. Despite poor image quality in the 
early 1960s the growth of the fetal biparietal diameter 
was measured and growth charts constructed for the last 
two trimesters of pregnancy. Ultrasound also contributed 
since it can be used to detect the numbers of fetuses,
- 17 -
fetal position, placental location and the estimation of 
fetal age and growth. Due to continuous improvement in 
image quality, coupled with expanding experience, 
ultrasound has become an important diagnostic aid not 
only in the field of obstetrics and gynaecology but in 
almost every other branch of medicine.
1.1.2 The nature of ultrasound
Ultrasound is the name given to sound waves with 
frequencies beyond the range of human hearing, i.e. 
greater than 20 KHz. Audible sound spreads out from its 
source in a fashion similar to waves on a pond. 
Ultrasound can be made to be more directional and easily 
directed in a beam and can therefore be used 
diagnostically. The range available for diagnostically 
usable ultrasound is 1-10 MHz. Ultrasound is generated by 
a device, an ultrasonic transducer, using a piezo-electric 
element, this converts electrical energy into mechanical 
energy, which is propagated by vibration of the small 
elements of the media through which it travels. Some 
energy is reflected by interfaces in the tissue and the 
transducer acts a receiver able to convert the reflected 
ultrasound into electrical signals.
- 18 -
1.1.3 Instrumentation
The diagnostic ultrasound systems in general use can be 
divided into two groups, the A, and B scan machines which 
employ pulsed ultrasound, and the simpler doppler or 
motion-sensing machines which use continuous wave 
ultrasound (Burel & Kjaer, 1978; Chudleigh & Pearce, 
1986).
Physical principle
In any ultrasonic equipment for medical diagnostics, the 
most vital part is the transducer which acts both as 
transmitter and receiver of ultrasound. Electrical 
impulses from the transmitter in the equipment are fed to 
the system's transducer and converted into rapid pressure 
oscillations of short duration. The resulting wave front 
is directed by the transducer into the tissue in a narrow 
beam. Whenever it hits a boundary between two tissues of 
different acoustic characteristics some of the energy will 
be reflected, the rest being transmitted and continuing 
into the tissue giving further reflection. If the 
boundary is perpendicular to the ultrasound beam, the 
reflected energy will go straight back to the transducer. 
The tranducer will convert some of the acoustic energy 
into electrical signals, which are fed to an amplifier
- 19 -
with an electronic depth attenuation compensation circuit, 
and eventually displayed on a screen or registration paper 
in one or more of several possible formats. Diagnosis by 
ultrasound is made by interpretation of echoes. These are 
produced from the reflection or scattering of ultrasound 
at tissue interfaces or from scattering from the 
heterogeneous structures within tissue. An echo is 
produced at a tissue interface if the acoustic impedance 
of the tissues on either side are different. The acoustic 
impedance of a tissue is a measure of the resistance of 
the tissue to the flow of ultrasound energy and is 
dependent upon the density of that medium. Information 
from returning echoes can be displayed in one of three 
ways, amplitude (A) mode, amplitude (B) mode and time 
motion (T-M) mode.
(A) mode display
In the simple A-mode equipment, the detection and display 
of the echoes are performed by horizontally sweeping a 
trace across an oscilloscope screen started at the 
emission of the ultrasound pulse. The screen is 
calibrated with distance markers so that the horizontal 
position will correspond to the depth in tissue and the 
detected echoes will deflect the trace vertically in 
proportion to the reflection amplitude (Fig. 1).
- 20 -
transducer
SCAN DISPLAY 
time, distance
echo
amplitude
reflections from 
interfaces
emission of 
ultrasound pulse
Figure 1: A - mode display
Transducer
Figure 2: A diagram to illustrate how coalescing echoes 
form a two-dimentional image of the fetal 
head in B-mode scanning.
This type of display has its main uses in cardiology and 
ophthalmology. It is also important as an aid to 
determining the amplitude differences between the echoes 
displayed in some of the more complex formats. The main 
advantage of an A-mode equipment is its simplicity and the 
aid it gives to determine the optimum tranducer position 
and equipment setting. However, it cannot display echoes 
other than those which fall in a single line in the tissue 
along the transducer axis. As it gives no two-dimensional 
information and since amplitude of the echoes depends on 
the angle of incidence, the transducer is difficult to 
orientate, except when used for cardiological purposes 
where the characteristic movements of certain parts of the 
heart can be used to orientate the transducer. Thus this 
type of equipment has been used for the examination of 
certain characteristic parts of the heart, the 
localization of such easily recognised structures as the 
midline of the brain, for measuring the BPD of the fetus 
and for looking at fetal heart movement. A-mode display 
is now rarely used in obstetric application.
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B-mode display
In B-mode scanning the returning echo is converted into a 
voltage and then displayed at the appropriate point on the 
screen as a bright spot. When these spots coalesce they 
produce a two-dimensional image (Fig. 2 ).
1. Static B-mode display
By converting the vertical deflection on the A- 
representation to light dots on the time-baseline, a two- 
dimensional so called B-mode picture can be made if the 
baseline is tilted and positioned according to the 
position and direction of the transducer cross-section in 
the scanning plane chosen. This can be achieved if the 
transducer is mounted on a scanning arm or frame and the 
echo dots are stored on the display as the transducer is 
moved by hand over the skin surface. This method of 
scanning (Fig. 3), has been widely used in abdominal 
diagnostics, and in gynaecology and obstetrics.
2. Real-time B-mode
Instead of moving the transducer by hand in order to look 
in various direction inside the patient it is possible to 
move the beam of ultrasound electronically or by a small
- 22 -
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Inferior Vena Cava
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Stomach and Bowels
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A-mode Display
Amplitude of Reflection
Depth in Tissue
B-mode Display
X-coordinate
Y-coordinate
Figure 3: Static B-mode display.
motor. It is possible to do this very rapidly, repeating 
the scan at up to 30 or 40 times per second. This 
produces a "cine" image as opposed to a static one and is 
usually called a real-time image. Real-time B-mode may be 
performed by three means: mechanical sector scanners,
electronic linear array scanners and electronic phased 
array scanners. The ultrasound equipment principally used 
in obstetrics is the linear array real time scanner. 
Occasionally the mechanical sector scanner or phased array 
scanner is preferred in early pregnancy or for specialised 
indications such as fetal cardiac scanning because of the 
smaller tranducer head.
Time-motion display
If an object is moving, the A-mode representation will 
show the corresponding echoes moving in the horizontal 
direction. By converting these to light dots, and by
slowly displacing them with fixed velocity, a number of 
curves can be stored indicating the movements of the
structures under study as shown (Fig. 4) . This type of
display is called the time-motion display, and is used
mainly in cardiology.
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Moving Object
Transducer
A-mode Display
B-mode Display
Time-motion Display
Figure 4: Build-up of .a time-motion display.
1.1.4 Safety of diagnostic ultrasound
A great deal of animal and human research has been 
undertaken in the past decade on the biological effect of 
ultrasound, though no reliable evidence has been produced 
to suggest that diagnostic ultrasound is harmful at the 
power levels used in clinical work. The mechanisms whereby 
ultrasound exerts biological effects on tissues may be 
divided into : heat generation and mechanical effects,
including acoustic cavitation, microstreaming and 
radiation pressure force. There is currently no
experimental evidence to show that heating, cavitation, 
microstreaming or radiation pressure force produces any 
significant effect on human tissues under diagnostic 
ultrasound imaging conditions (Kremkau, 1983).
In clinical studies, no surveys have shown an association 
between the antenatal use of ultrasound and the incidence 
of either congenital abnormalities (Heilman et al, 1970; 
Scheidt et al, 1978; Stark et al, 1984), or intrauterine 
growth retardation (Wladimiroff & Laar, 1980). 
Furthermore, many reassuring statements have been issued 
on ultrasound safety e.g. by the American institute of 
Ultrasound in Medicine (AIUM, 1983), the European 
Federation of Societies for Ultrasound in Medicine and 
Biology (EFSUMB, 1984), the British Medical Ultrasound
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Society (BMUS, 1984) and the Report of the Royal College 
of Obstetricians and Gynaecologists (RCOG) Working Party 
on Routine Ultrasound Examination in Pregnancy (1984). 
While additional information regarding the safety of 
ultrasound is considered necessary and is still being 
sought, its clinical usefulness outweighs any hypothetical 
risk, and the use of ultrasound is recommended for the 
proper care of obstetric patients (RCOG Working Party on 
routine ultrasound examination in pregnancy, 1984).
1.1.5 Indications for diagnostic ultrasound in obstetrics
The use of diagnostic ultrasound in obstetrics has 
increased rapidly in the last decade. Although the 
utilisation of ultrasound in obstetrics has been based 
initially on the confirmation of pregnancy, diagnosis of 
multiple pregnancy, estimation of gestational age and 
diagnosis of placenta praevia, the most essential uses are 
the detection of IUGR and congenital malformation. 
Furthermore, there is a substantial body of literature 
which indicates that ultrasound is diagnostically helpful 
in many clinical situations. Report of the RCOG Working 
Party on routine ultrasound examination in pregnancy 
(1984) agreed on most of the 28 clinical situations 
described in the report of the National Institutes of
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Health Consensus statement (NIH, 1984) where ultrasound 
could be of benefit in the resolution of antenatal 
problems. These are the following
1. Bleeding or pain in early pregnancy; to exclude ectopic 
pregnancy, to establish fetal viability and attempt to 
find the source of the bleeding.
2. Vomiting in early pregnancy; to diagnose hydatidiform 
mole, multiple pregnancy or other possible causes of the 
disorder.
3. Estimation of gestational age when mothers present with 
unreliable menstrual dates or have had bleeding in early 
pregnancy or have oral contraceptives within two months of 
the last menstrual period.
4. Detailed anatomical examination of the fetus when there 
is a strong family history of congenital abnormality, when 
there is an associated condition which increases the risk, 
such as diabetes or polyhydramnios or when maternal serum 
alphafetoprotein (AFP) levels are raised.
5. Adjunct to prenatal diagnostic invasive procedures, 
such as chorion biopsy, amniocentesis, fetoscopy or
- 26 -
prenatal surgical procedures such as the placement of a 
vesico-amniotic shunt.
6. A discrepancy between dates and fundal height of three 
or more weeks. If the fundus is 'large for dates' to 
exclude fetal macrosomy, multiple gestation, polyhydram­
nios, hydrops fetalis or associated tumours. If 'small for 
dates' to exclude fetal growth retardation and oligohyd­
ramnios which may be related to IUGR, fetal renal 
abnormalities, premature rupture of the membranes or post­
maturity.
7. To monitor fetal growth with serial measurements when 
IUGR is clinically suspected or when there is a previous 
history of IUGR babies or stillbirths, or when there is a 
multiple pregnancy. Also in diabetic pregnancy, to 
diagnose acceleration of growth associated with macrosomy.
8. Antepartum haemorrhage; to diagnose placenta praevia 
and to assess the relationship of the lower edge of the 
placenta to the cervix which can change with the unfolding 
of the lower uterine segment. To identify retroplacental 
bleeding where there is a normally situated placenta.
9. Fetal weight assessment; this is valuable in circums­
tances where early delivery is contemplated due to
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complications such as premature rupture of the membranes, 
severe hypertension or IUGR for it may give guidance as to 
the timing and method of delivery.
The accuracy of ultrasound scanning is very dependent on 
the skill of the doctor or technician performing the scan. 
This is more true for ultrasound diagnosis than for other 
types of investigation such as biochemistry, radiology or 
nuclear medicine where fairly standardised procedures are 
adopted. Ultrasound demands the ability to interpret 
images and adapt the scan technique, gain control and 
dynamic focus settings of the equipment, according to the 
position of the fetus, the size of the mother, the amount 
of amniotic fluid and many other variables.
In Scotland, the survey of the RCOG Working Party on 
routine ultrasound examination in pregnancy (1984) 
comprised 29 hospitals with an obstetric service 
responsible for the vast majority of the Scottish annual 
births. It showed that 53% of the hospitals performed one 
routine scan, 10% two routine scans and 3% three routine 
scans. Thus 66% of the hospitals surveyed performed at 
least one routine antenatal scan. Some hospitals
performed a scan at the mother's first visit to the 
hospital while others delayed the scan to between the 
16th and 18th week in order to obtain more information.
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1.2 Objectives of the Study
The aims of this study are threefold;
1. To display the birthweight distribution as a function 
of gestational age for all women attending The Queen 
Mother's Hospital antenatal clinic, who had ultrasound 
dating of gestational age in early pregnancy and to 
compare it with the Scottish Standards.
2. To evaluate the effectiveness of various ultrasound 
measurements and combinations of measurements for the 
antenatal detection of IUGR. The measurements studied were 
biparietal diameter (BPD), head area (HA), head 
circumference (HC), abdominal area (AA), abdominal 
circumference (AC), femur length (FL), amniotic fluid 
volume (LV), the product of abdominal area and femur 
length (AAFL), the product of abdominal circumference and 
femur length (ACFL).
3. To study the association of intrauterine growth 
retardation with perinatal mortality and congenital 
malformation.
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CHAPTER 2 
MATERIALS AND METHODS
2. MATERIALS AND METHODS
2.1 Source of Data
All patients attending The Queen Mother's Hospital 
antenatal clinics are offered a scan at the time of 
booking to establish an accurate gestational age, and to 
diagnose multiple gestation and major fetal abnormalities. 
Further scans are carried out for a specific indication 
such as bleeding or suspected IUGR.
Since 1985, there has been an ongoing process of recording 
and verifying the data obtained by the Department of 
Ultrasound in the hospital. Data regarding each patient 
are classified in nine major categories: general
history, current pregnancy history, booking data, early 
pregnancy failure, placentography, retained products of 
conception, prenatal diagnosis, fetal growth, pelvic 
masses and delivery details (Fig. 5). A data sheet for 
each pregnancy is completed by the ultrasonographer and 
taken to the Ultrasonic Technology Laboratory of the 
University Department of Midwifery at the hospital for 
storage in the University mainframe computer to provide a 
research data base. Following entry the validity of the 
data is checked using a programme written in COBOL. This 
applies an elaborate sequence of comparisons to check that
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Figure 5: The data recording sheet used for each patient.
each individual data item is within "an acceptable range " 
and that the relationship of groups of data items was 
"acceptable" e.g. given a gestational age is the BPD 
reasonable for that age. The validated data were then 
processed by a Statistical Package for Social Science 
(SPSSX) data definition programme which assigned variable 
names (used for formal reference to the variables in the 
processing commands), variable labels (used to give a 
readily understood description of the output) and value 
labels (to translate the code values assigned to a given 
variable) (Fig. 6). The defined data were stored in a 
SPSSX system file for access by analysis programmes such 
as those described in this study (programmes 1-81). The 
arrangement of data in this file was not suitable for all 
the analyses. Therefore rearranged files were generated 
in which all measurements of one type are recorded under 
one variable name e.g BPD1, BPD2, BPD3, BPD4 were combined 
under the variable name BPD.
The computerised data bases provided by the Ultrasound 
Department were used as a material for this study. Data 
were programmed for selection of population and 
statistically analysed using SPSSX package on the 
University Mainframe Computer (ICL 3980). Some
computations were performed using the MINITAB package for 
graphic work (available in the Department of Midwifery on
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Figure 6 (A, B, C & D) 
Ultrasound data definition programme
V A R IA B L E  NAM E D E T A IL S  (Codes are:t=0=NO,1=YES. #=NLIMBER OF) D A T A  IT E M
-   .......             - ~ ---------      - -....... -....  NUM BER
G E N E R A L  H IS T O R Y
QMHNO Queen Mother’ s Hospital Number 1
U S N O  Ultrasound Number (used when no QMHNO) 2
C AR D N O  Card Number 3
F E T A L N Q  Fetal Number 4
T R A N S  Transfer (from another hospital) t 5
R E F U S E D  Ultrasound Refused (by patient) t 6
N O U S NO Ultrasound 7
T O T S C A N S  Total Number of Scans in  th is  pregnancy* 8
D E F A U L T  i  Defaults 9
A G E  Age (yrs) 10
P A R IT Y  I  Previous Pregnancies > 28 weeks 11
A B 0 R T S P 1 /2  i  Spontaneous Abortion in lst/2nd Trimester 12-13
T H E R 1 /2  # Therapeutic Abortion in lst/2nd Trimester 14-15
P A S T  M E D IC A L  H IS T O R Y
R H A B  Rhesus or other Antibodies t  16
B P  Hypertension % 17
C A R D IA C  Cardiac Disease t IB
D I A B E T I C  Diabetes t 19
O T H E R  Other Medical Problem t 20
P A S T  O B S T E T R IC  H IS T O R Y
S B  I  S t i l lb ir th  21
N ND  # Neonatal Death 22
FAS)A Fetal Abnormality Code A 23
0 No Fetal Abnormality 1 Neural Tube Defect 
2 Abdominal Wall Defect 3 Urinary Tract Defect 
4 Skeletal Defect 5 Chromosome Defect
6 Rhesus Disease 7 Cardiac Defect 8 Other 
P T D  Preterm Delivery 24
IU G R  Intrauterine Growth Retardation 25
C U R R E N T  P R E G N A N C Y  H IS T O R Y
T H R E A T  1 / 2  Threat in 1st/2nd Trimester t 26-27
A P H  Antepartum Haemorrhage t 28
PRM  Premature Rupture of Membranes t 29
B P C P H  Hypertension I 30
P O L Y  Polyhydramnios Or Oligohydramnios I 31
M S A F P 1 /2  1= t/2nd Maternal Serum Alphafetoprotein 32,34
A T W K S 1 / 2  « Weeks lst/2nd MSAFP Sample Taken 33,35
N Q R ESa)K  No MSAFP Result Code K 36
1 Declined 2 Missed 3 Done Elsewhere 
S E R IA L  Serial MSAFP’ s t 37
V A R IA B L E  NAME D E T A IL S  (Codes are:l=0=NQ,1=YES. ft=NUMBER OF) DATA IT E M
................              NUM BER
B O O K IN G  D A T A
V IA B L E Viable Fetus t 38
N O F E T U S ft Fetuses 39
L M P D /M /Y Last Menstrual Period((Day)/(Month)/(Year)) 40-42
C E R T Certain of Dates I 43
OC Oral Contraception Within 3 Months of Conception t 44
C Y C L E Length of Menstrual Cycle in Days 45
0 Menstrual Cycle Irregular
G E S T D A T E Gestation by Dates (Weeks/Days) 46
U S Gestation by Ultrasound (Weeks/Days) 47
E XA M Gestation by C lin ica l Examination (Weeks) 48
D A T E S O K Gestation by Dates Confirmed by Ultrasound t 49
U S E D D D /M /Y Ultrasound Estimated Delivery Date(Day/Mth/Yr) 50-52
N O U S B K ft Scans fo r Gestational Age 53
E A R L Y  P R E G N A N C Y  F A IL U R E /P R O B L E M S
R E F E R 3 B  Referral Code B 54
1 Booking,Ante Natal C lin. 2 Gen. Pratitioner 
3 Self 4 Western In f. Glasgow
5 Royal Samaritan Hosp 6 B r it, Preg. Advisory Serv.
/Family Planning Ass.
7 Ante Natal C lin ic  8 Past History 9 Other 
D IA G S C  Diagnosis Code C 55
1 Viable pregnancy 2 Not pregnant
3 Blighted ovum 4 Missed abortion
5 Complete/Incomp, abortion 6 Mole
7 Ectopic 8 In tra  Uterine Death
N O U S E P F  I  Early Pregnancy Problems 56
Y Q L K S A C  Yolk Sac % 57
S E C S A C  Second Sac Present t 58
N Q U SS G  i  Scans for Serial Growth 59
P L A C E N T O G R A P H Y
IN D IC 3 D  Indication Code D 60
1 Antepartum Haemorrhage 2 Threat
3 Abnormal l ie  4 Breech
5 High presenting part 6 Ultrasound coincidental
7 Abdominal pain 8 Raised Alphafetoprotein
L T 2 8 W K S  < 28 Weeks 61
1 Low 2 Normal
A R E A B L  Area of Bleeding 62
1 Sub Chorionic Haematoma 2 Retroplacental c lo t 
3 Other
N 0 U S L T 2 8  ft Scans at < 28 Weeks 63
G E28W KS )E  >= 28 Weeks Code E re:Placenta Praevia 64
1 diagnosed 2 excluded 3 s ite  uncertain 
S U B M O VE  Subsequent Move Of Placenta t 65
S IT E C O N F  Site Confirmed 66
N 0 U S G E 2 8  4 Scans at >=28 Weeks 67
R PC 5)F Retained Products Of Conception Code F 68
1 Uterus empty 2 Clot & tissue 3 Clot 4 Uncertain 
E V A C  Evacuation of Uterus I 69
N O U SR P C  ft Scans for Retained Products Of Conception 70
V A R IA B L E  N AM E D E T A IL S (Codes are:*=0=NO,1=YES. ft=NUMBER OF) D A T A  IT E M
  ................................................ ... .......................... ................ ...........- ..........   NUM BER
P R E N A T A L  D IA G N O S IS
IN D IC 5 )G  Indication Code G 71
i Past History 2 Family History 3 Age
4 C lin ical suspicion 5 Ultrasound suspicion
6 Raised Or Missed Alphafetoprotein 7 Twins 
8 Growth problem 9 Complex
C V S  Chorion V illu s  Sampling or Fetoscopy t 72
N O U SP N D  ft Scans for Prenatal Diagnosis 73
F E T A B N 0 A  Fetal Abnormality Code A (See FA5A) 74
N O A M N IO  I  Amniocenteses 75
N O U S P R E S  ft Scans for Presentation 76
N O U S E C V  f  Scans for External Cephalic Version 77
M U L T P R E G  M ultiple Pregnancy I 78
W H EN D E T When Multiple Pregnancy Detected (Weeks) 79
GROW TH
IN D IC 3 H
N O U SG R
D A T E 1 D - 4 Y
W K S 1 - 4
C R L 1 - 4
B P D 1 - 4
F L 1 - 4
H C 1 - 4
H A 1 - 4
T C I - 4
T A 1 - 4
E F W 1 - 4
H T 1 —4
L V 1 - 4
P L A C M A T 1 - 4  
L S R 1 - 4
Indication Code H
1 Past History Intra Uterine growth retardation
/smallish baby 2 Past H ist, macrosomia
3 Past History/Current History of Fetal Abnormality
4 C lin ica lly  Small For Dates 5 C lin. Large For Dates 
6 Raised Blood Presure 7 Diabetes
8 Antepartum Haemorrhage/Threat/Abdominal pain
9 Research 10 Twins 11 Spont. Rupture Of Membranes
12 Late date 13 Preterm labour 14 Rhesus 15 Breech
16 Raised Alphafetoprotein 17 Term/Post dates
18 Decreased fe ta l movements 19 Complex
ft Scans for Growth 
Day/Mth/Yr of ls t-4 th  Scan
ft Weeks Pregnancy at Scanl - 4
Crown Rump Length, mm "
Biparietal Diameter, mm "
Femur Length, mm "
Head Circumference, mm "
Head Area, sq cm "
Abdominal Circumference, mm "
Abdominal Area, sq cm "
Estimated Fetal Weight, g /10 "
Head Abdomen Ratio, x100 "
Liquor Volume, mm "
Placental Maturity, grade *
Lethicin Sphyngomyelin Ratio, no longer used
81
82-93
94-97
98-101
102-105
106-109
110-113
114-117
118-121
122-125
126-129
130-133
134-137
138-141
142-145
P E L V I C  M A S S E S
F I B R  Fibroids t
C Y S T S  Cysts t U7
IU C D  Intra Uterine Contraceptive Device % 148
A L L O T H E R  Other % 149
V A R I A B L E  N A M E  D E T A I L S  (Codes are:t=0=NO,1=YES. ft=NUHBER OF)
D E L I V E R Y  D A T A
N O F E T U S D
D A T E D / M / Y
I N D
M 0 D E 3 J
W K S
W G H T
S E X
F A D E L 0 A
P N R W
E O R M A R K
ft Fetuses Delivered
Date of Delivery((Day)/(Month)/(Year)) 
Induction of labour t 
Mode of Delivery 
1 Spontaneous Vertex Delivery 
3 Ventouse
5 Elective Caesarian Section
6 Emergency Caesarian Section 
8 Termination Of Pregnancy 
ft Complete Weeks of Pregnancy at Delivery 
Weight of Baby at B irth , g/10
Sex of Baby, M/F
Fetal Abnormality at B irth  Code A (See FA3A) 
Perinatally Related Wastage 
End of Record Mark
D A T A  I T E M  
N U M B E R
150
151-153
154
155
2 Forceps 
4 Breech
7 Spontaneous Abortion 
9 Evacuation
156
157
158
159
160 
161
V A R I A B L E S  A D D E D  L A T E R
B R N A L V Born Alive
1 Born Alive 2 S tillbo rn  9 No Data Available
V A R I A B L E S  G E N E R A T E D  B Y  D A T A  D E F I N I T I O N  P R O G R A M
B W C T 1
B W C T 2
Birthweight centile  codes based on 
Smalls, M., Forbes, J.F. (1983)
an Amstrad 1640 Microcomputer). The t-test and chi-square 
test were applied where appropriate. Other statistical 
procedure as the Law of Total Probability and its 
variation were also used in this study.
2.2 Equipment
All examinations and the fetal measurements were carried 
out using: a/ Diasonics DRF400 which was fitted with 3.5 
and 5 MHz mechanical sector tranducers (Fig. 7). The 
measuring facility was improved by the addition of a 
Diagnostic Sonar Ltd Echo-computer; b/ Dynamic Imaging 
"Concept" which was fitted with a 3.5 MHz linear array 
transducer (Fig. 8); c/ Dynamic Imaging "XLP" which was 
fitted with a 3.5 MHz linear array transducer (Fig. 9). 
The ultrasound velocity was 1540 m/second. Measurements 
were made on screen by the use of an electronic light pen.
2.3 Measurement Techniques
The ultrasound measurements performed were: biparietal
diameter (BPD), head area (HA), head circumference (HC), 
abdominal area (AA), abdominal circumference (AC), femur 
length (FL) and amniotic fluid volume (LV).
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Figure 8: Dynamic imaging "Concept" scanner
SYSTEM XLP LINEAR SCAWNE:
UJVlhT
Figure 9: Dynamic imaging "XLP" scanner.
Biparietal diameter
A series of scans was performed to find the long axis of 
the fetus. The probe was then rotated by 90 degrees to 
this axis, and angled so that a transverse plane of the 
fetal head was imaged. A series of parallel sections were 
then imaged to identify the following land-marks: short 
midline, cavum septum pellucidum, thalami and basal 
cisterns. An adequate BPD measurement was obtained when 
the thalami and midline were visualised. However the 
inclusion of the other two features was necessary for the 
head area and head circumference measurements (Fig. 10). 
Having identified the correct section, a BPD measurement 
was made on a frozen image from the leading portion of 
echo from proximal skull surface to leading portion of 
echo from distal skull surface (Fig. 11). In this way 
error associated with changes in the position of the echo 
peak can be avoided. Measurements made across the beam 
axis are known to be less accurate than those along the 
beam axis. The measurement was repeated until three 
successive readings agreed to within 1 mm. The average of 
these was taken as the BPD reading (Evans et al, 1987).
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Figure 10: Diagrammatic representation of a transverse 
section of fetal head for measurement of 
BPD, HC and HA.
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Figure 11: Ultrasonic image of the transverse section 
of the fetal head on which the BPD, HC and 
HA should be measured.
Head area and circumference
The plane for these measurements was obtained from a 
transverse ellipsoid section of the fetal head displaying 
the following land-marks: short midline, cavum septum
pellucidum, thalami and basal cisterns. When a
satisfactory image was obtained the circumference was 
measured by tracing along the the outer edge (Fig. 11). 
Using the same plane area measurements were obtained (Fig. 
11) .
Abdominal area and circumference
The long axis of the fetus was found by obtaining a 
longitudinal section through the fetal spine or aorta. 
The aorta is preferable to the spine as it is not as wide 
as the spine and consequently using the aorta will 
minimise the degree of obliquely to the true longitudinal 
plane. The transducer was then rotated through 90 degrees 
to obtain a transverse image of the fetus at the level of 
the umbilical vein. The transverse section should be 
circular in outline and show the portion of the umbilical 
vein situated almost centrally as it enters the portal 
system within the liver (Fig. 12). When a satisfactory 
image was obtained the circumference was measured by
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Figure 12: Diagrammatic representation of a transverse 
section of fetal abdomen for measurement of 
AC and AA.
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Figure 13: Ultrasonic image of the transverse section 
of the fetal abdomen for measurement of AC 
and AA.
tracing along the outer edge (Fig. 13). Using the same 
plane area measurements were obtained (Evans et al, 1989).
Femur length
The long axis of the fetus was found and the femora 
identified as the single long bones at its caudal end. To 
ensure that the whole of the femur was measured and was 
not foreshortened, the transducer would have to be rotated 
until the longest possible image of the femur was obtained 
and the transducer was along the long axis of the femur. 
This image was then frozen. A straight line measurement
between the two ends was made (Fig. 14). On occasions,
the normal femur may have appeared slightly bowed but the 
measurement was still obtained as a straight line. This
measurement was repeated until three within 1mm of each
other were obtained and the largest of these was recorded 
(Evans, 1988).
Amniotic fluid volume
LV was measured as the maximum vertical depth (mm) of the 
deepest pool of fluid (pocket size) (Fig. 15).
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Figure 14: Image demonstrating straight 
measurement of FL.
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Figure 15: Ultrasonic image of LV measurement
CHAPTER 3
AN ANALYSIS OF BIRTHWEIGHT BY GESTATIONAL AGE 
OF INFANTS BORN IN THE QUEEN MOTHER*S HOSPITAL, 
GLASGOW, 1985-1987
3. AN ANALYSIS OF BIRTHWEIGHT BY GESTATIONAL AGE OF
INFANTS BORN IN THE QUEEN MOTHER1S HOSPITAL, GLASGOW, 
1985-87
3.1 Introduct ion
Birthweight is generally known as a most potent indicator 
of fetal growth and of the risk of both mortality and 
morbidity in the neonate. The importance of accurate and 
valid fetal growth standards which describe the 
distribution of birthweight for gestational age, has long 
been acknowledged. Such standards based on the analysis 
of data from live born infants have been used in three 
principal ways. First, they have provided widely adopted 
criteria for assessing fetal growth and development at 
birth (Lubchenco et al, 1963; Thomson et al, 1968; Miller 
& Richard, 1974). Secondly, they have been used to assess 
the validity and predictive value of antenatal screening 
tests for fetal growth retardation based on such 
techniques as fundal height measurement (Quaranta et al, 
1981; Rosenberg et al, 1982) and ultrasound measurement 
(Campbell & Wilkin, 1975; Neilson et al, 1980). Thirdly 
they have been used to draw nomograms for precise 
determination of birthweight for gestational age (Altman & 
Coles, 1980).
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Beginning with the early studies of Scammon and Calkins 
(1929), the need for accurate data to describe the 
relationship between birthweight and gestational age has 
generated numerous standards for a variety of populations. 
Most of these standards are unsatisfactory because of the 
inconsistencies in methodology, for example inclusion of 
both live and stillbirths in the analysis (McKeown & 
Gibson, 1951). Moreover, some of them described all 
births, irrespective of sex, parity or maternal size which 
have, later, been found to have an effect on birthweight 
(Thomson et al, 1968; Milner & Richards, 1974; Forbes & 
Smalls, 1982). Even when a sex difference was described, 
it was usually ignored. For example, Lubchenco and 
associates (1963) noted that sex differences were small 
compared with the range of weights at any gestation, and 
described the uses of an overall (both sexes) standards 
only. Standards based on Scottish populations have been 
reported for Aberdeen (Thompson et al, 1969), Scotland 
(Cole, 1981; Forbes & Smalls, 1982),and Glasgow (Forbes & 
Smalls, 1983). These studies relied on clinical
estimation of gestational age which has been shown to be 
less accurate than ultrasound dating prior to 20 weeks 
(Campbell, 1974). Demographic, social, environmental and 
possibly biological factors characterising the 
reproductive experience of Scottish women have changed 
over the years and it is hoped that this study may provide
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more accurate data of contemporary birthweight 
distribution according to gestational age as ascertained 
by ultrasound.
This study presents means, standard deviations and centile 
values of birth weight for gestational age, subdivided by 
the sex of infants and parity of mother, based on the 
analysis of live births occurring to women attending the 
Queen Mother's Hospital in Glasgow between 1985 and 1987. 
The basic purpose of this study is to provide the local 
standard for monitoring the birthweight of all infants 
born in the QMH.
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3.2 Patients and methods
From the computerised ultrasound and perinatal data bases 
(Fig. 5 & 6 ), birthweight, gestational age and various
demographic and clinical information were obtained by 
using programmes (1-6) and SPSSX software.
The study population was selected by applying programmes 
(1-3). Ten thousand two hundred and fifty nine (10259) 
live singleton births occurring between 1985 and 1987 (QMH 
Group 1) were considered. This sample represented 26% of 
total live births in Greater Glasgow Health Board (GGHB) 
area and 5.2% of all live births in Scotland (Annual 
Report-Registrar General Scotland (1985, 1986 & 1987).
Gestational age was confirmed by ultrasound prior to 20 
weeks of gestation. Tables were prepared showing the mean, 
standard deviation and 5th, 10th, 25th, 50th, 75th, 90th
and 95th smoothed centiles, of birthweight by gestational 
age for each week of gestation from 28 to 42 weeks 
gestation. Separate tables were provided for the 
following subgroups (1-6):-
1. All pregnancies with male infants.
2. All pregnancies with female infants.
3. All primiparae with male infants.
4. All primiparae with female infants.
5. All multiparae with male infants.
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6. All multiparae with female infants.
To allow comparison with other reported standards and to 
provide a better representation of the pattern of fetal 
growth , the actual centile values were smoothed.
A similar analysis was repeated on a subset of 3919 
births (QMH Group 2) selected from the above sample using 
programmes (4-6) written in SPSSX . Women included in this 
group had to meet the following criteria: (1) their
babies were born without congenital malformation; (2 ) 
spontaneous onset of labour; (3) not on the contraceptive 
pill for the three months before pregnancy; (4) certain 
date of last menstrual period; (5) gestational age 
confirmed by ultrasound prior to 20 weeks. QMH Group 2 
was subdivided in to six subgroups (7-12) corresponding 
to the subgroups of QMH Group 1.
Separate tables were prepared for each of the subgroups, 
from which the mean, standard deviation and the 5th, 
10th, 25th, 50th, 75th, 90th and 95th smoothed centiles
distribution of birthweights (in Kg), at each week were 
calculated.
Using the MINITAB statistical package, version 7.1 
(available in the Department of Midwifery on an Amstrad
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1640 microcomputer), curves of the 5th, 10th, 50th, 90th, 
and 95th centiles of the distribution from the 28th to 
42nd weeks, for the subgroups (1-12) were constructed. 
These curves were super-imposed on the centiles curves 
derived from live births of Scotland 1975-79 (Smalls & 
Forbes, 1982) (Fig. 16-27 - following page 58).
The effect of the sex on birthweight for babies born to 
primiparae was examined. A t-test was performed on the
difference between the mean birthweight of males and
females (subgroups 3 & 4), so as to control for the
influence parity might have on birthweight. Similarly, 
the effect of parity on birthweight was also examined. A 
t-test was performed on the difference between the mean 
birthweight of males born to primiparae and to multiparae 
(subgroups 3 & 5).
To determine the effect of induction of labour on the 
distribution of birthweight for gestational age, the QMH 
Group 1 (male infants) was divided into case and control 
groups. The cases comprised 989 women with induced labour, 
while the controls consisted of 4292 women with a 
spontaneous labour, so as to control for the influence 
baby's sex might have on birthweight. A t-test was
performed on the difference between the mean birthweight 
of cases and controls.
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FILE HANDLE A /NAME=':GOUA02.US85.SPFQMH85'
FILE HANDLE B /NAME=':G0UA13.US86.SPFQMH86'
FILE HANDLE C /NAME=':GOUA07.US87.SPFQMH87'
ADD FILES FILE=A/FILE=B/FILE=C
SELECT IF N0FETUSD=1
SELECT IF WKS GT 27
SELECT IF PNRW EQ 0
TEMPORARY
SELECT IF SEX='m '
/ TABLE = WKS BY WGHT
/ STATISTICS = COUNT (WGHT) MEAN (WGHT(F3.2)) 
STDDEV (WGHT(F3.2)) RANGE (WGHT(F3.2))
PTILE 5 (WGHT(F3.2)) PTILE 10 (WGHT(F3.2)) 
PTILE 25 (WGHT(F3.2)) PTILE 50 (WGHT(F3.2))
PTILE 75 (WGHT(F3.2)) PTILE 90 (WGHT(F3.2))
PTILE 95 (WGHT(F3.2))
TEMPORARY 
SELECT IF SEX ='f'
/TABLE = WKS BY WGHT
/STATISTICS = COUNT (WGHT) MEAN (WGHT(F3.2)) 
STDDEV (WGHT(F3.2)) RANGE (WGHT(F3.2))
PTILE 5 (WGHT(F3.2)) PTILE 10 (WGHT(F3.2)) 
PTILE 25 (WGHT(F3.2)) PTILE 50 (WGHT(F3.2))
PTILE 75 (WGHT(F3.2)) PTILE 90 (WGHT(F3.2))
PTILE 95 (WGHT(F3.2))
Programme 1: SPSSX programme to calculate statistics 
for "all pregnancies" in QMH Group 1 (as 
defined on p 39) for a/ male infants and 
b/ female infants.
SELECT IF N0FETUSD=1 
SELECT IF PARITY EQ 0 
SELECT IF WKS GT 27 
SELECT IF PNRW EQ 0 
TEMPORARY 
SELECT IF SEX=V
/ TABLE = WKS BY WGHT
/ STATISTICS = COUNT (WGHT) MEAN (WGHT(F3.2)) 
STDDEV (WGHT(F3.2)) RANGE (WGHT(F3.2))
PTILE 5 (WGHT(F3.2)) PTILE 10 (WGHT(F3.2)) 
PTILE 25 (WGHT(F3.2)) PTILE 50 (WGHT(F3.2))
PTILE 75 (WGHT(F3.2)) PTILE 90 (WGHT(F3.2))
PTILE 95 (WGHT(F3.2))
TEMPORARY 
SELECT IF SEX ='?'
/TABLE = WKS BY WGHT
/STATISTICS = COUNT (WGHT) MEAN (WGHT(F3.2)) 
STDDEV (WGHT(F3.2)) RANGE (WGHT(F3.2))
PTILE 5 (WGHT(F3.2)) PTILE 10 (WGHT(F3.2)) 
PTILE 25 (WGHT(F3.2)) PTILE 50 (WGHT(F3.2))
PTILE 75 (WGHT(F3.2)) PTILE 90 (WGHT(F3.2))
PTILE 95 (WGHT(F3.2))
Programme 2: SPSSX programme to calculate statistics 
for "all primiparae" in QMH Group 1 (as 
defined on P39 ) for a/ male infants and 
b/ female infants.
SELECT IF N0FETUSD=1 
SELECT IF WKS GT 27 
SELECT IF PNRW EQ 0 
SELECT IF PARITY GT 0 
COMPUTE WGHT=WGHT/1000 
TEMPORARY 
SELECT IF SEX=V
/ TABLE = WKS BY WGHT
/ STATISTICS = COUNT (WGHT) MEAN (WGHT(F3.2)) 
STDDEV (WGHT(F3.2)) RANGE (WGHT(F3.2))
PTILE 5 (WGHT(F3.2)) PTILE 10 (WGHT(F3.2)) 
PTILE 25 (WGHT(F3.2)) PTILE 50 (WGHT(F3.2))
PTILE 75 (WGHT(F3.2)) PTILE 90 (WGHT(F3.2))
PTILE 95 (WGHT(F3.2))
TEMPORARY 
SELECT IF SEX ='?'
/TABLE = WKS BY WGHT
/STATISTICS = COUNT (WGHT) MEAN (WGHT(F3.2)) 
STDDEV (WGHT(F3.2)) RANGE (WGHT(F3.2))
PTILE 5 (WGHT(F3.2)) PTILE 10 (WGHT(F3.2)) 
PTILE 25 (WGHT(F3.2)) PTILE 50 (WGHT(F3.2))
PTILE 75 (WGHT(F3.2)) PTILE 90 (WGHT(F3.2))
PTILE 95 (WGHT(F3.2))
Programme 3: SPSSX programme to calculate statistics 
for "all multiparae" in QMH Group 1 (as 
defined on p 39 ) for a/ male infants and 
b/ female infants.
SELECT IF N0FETUSD=1 
SELECT IF WKS GT 27 
SELECT IF PNRW EQ 0 
SELECT IF FADEL@A EQ 0 
SELECT IF IND EQ 0 
SELECT IF OC EQ 0 
SELECT IF CERT EQ 1 
SELECT IF DATESOK EQ 1 
TEMPORARY 
SELECT IF SEX=V
/ TABLE = WKS BY WGHT
/ STATISTICS = COUNT (WGHT) MEAN (WGHT(F3.2)) 
STDDEV (WGHT(F3.2)) RANGE (WGHT(F3.2))
PTILE 5 (WGHT(F3.2)) PTILE 10 (WGHT(F3.2)) 
PTILE 25 (W3HT(F3.2)) PTILE 50 (WGHT(F3.2))
PTILE 75 (WGHT(F3.2)) PTILE 90 (WGHT(F3.2))
PTILE 95 (WGHT(F3.2))
TEMPORARY 
SELECT’ IF SEX ='F'
/TABLE = WKS BY WGHT
/STATISTICS = COUNT (WGHT) MEAN (WGHT(F3.2)) 
STDDEV (WGHT(F3.2)) RANGE (WGHT(F3.2))
PTILE 5 (WGHT(F3.2)) PTILE 10 (WGHT(F3.2)) 
PTILE 25 (WGHT(F3.2)) PTILE 50 (WGHT(F3.2))
PTILE 75 (WGHT(F3.2)) PTILE 90 (WGHT(F3.2))
PTILE 95 (WGHT(F3.2))
Programme 4: SPSSX programme to calculate statistics 
for "all pregnancies" in QMH Group 2 (as 
defined on p Ho ) f°r a/ male infants and 
b/ female infants.
SELECT IF N0FETUSD=1 
SELECT IF WKS GT 27 
SELECT IF PNRW EQ 0 
SELECT IF FADEL@A EQ 0 
SELECT IF IND EQ 0 
SELECT IF OC EQ 0 
SELECT IF CERT EQ 1 
SELECT IF DATESOK EQ 1- 
SELECT IF PARITY EQ 0 
TEMPORARY 
SELECT IF SEX='M'
/ TABLE = WKS BY WGHT
/ STATISTICS = COUNT (WGHT) MEAN (WGHT(F3.2)) 
STDDEV (WGHT(F3.2)) RANGE (WGHT(F3.2))
PTILE 5 (WGHT(F3.2)) PTILE 10 (WGHT(F3.2)) 
PTILE 25 (WGHT(F3.2)) PTILE 50 (WGHT(F3.2))
PTILE 75 (WGHT(F3.2)) PTILE 90 (WGHT(F3.2))
PTILE 95 (WGHT(F3.2))
TEMPORARY 
SELECT IF SEX ='?'
/TABLE = WKS BY WGHT
/STATISTICS = COUNT (WGHT) MEAN (WGHT(F3.2)) 
STDDEV (WGHT(F3.2)) RANGE (WGHT(F3.2))
PTILE 5 (WGHT(F3.2)) PTILE 10 (WGHT(F3.2)) 
PTILE 25 (WGHT(F3.2)) PTILE 50 (WGHT(F3.2))
PTILE 75 (WGHT(F3.2)) PTILE 90 (WGHT(F3.2))
PTILE 95 (WGHT(F3.2))
Programme 5: SPSSX programme to calculate statistics 
for "all primiparae" in QMH Group 2 (as 
defined on p 4o ) for a/ male infants and 
b/ female infants.
SELECT IF N0FETUSD=1 
SELECT IF WKS GT 27 
SELECT IF PNRW EQ 0 
SELECT IF FADEL@A EQ 0 
SELECT IF IND EQ 0 
SELECT IF OC EQ 0 
SELECT IF CERT EQ 1 
SELECT IF DATESOK EQ 1 
SELECT IF PARITY GT 0 
TEMPORARY 
SELECT IF SEX=V 
/ TABLE = WKS BY WGHT
/ STATISTICS = COUNT (WGHT) MEAN (WGHT(F3.2)) 
STDDEV (WGHT(F3.2)) RANGE (WGHT(F3.2))
PTILE 5 (WGHT(F3.2)) PTILE 10 (WGHT(F3.2)) 
PTILE 25 (WGHT(F3.2)) PTILE 50 (WGHT(F3.2))
PTILE 75 (WGHT(F3.2)) PTILE 90 (WGHT(F3.2))
PTILE 95 (WGHT(F3.2))
TEMPORARY 
SELECT IF SEX ='?'
/TABLE = WKS BY WGHT
/STATISTICS = COUNT (WGHT) MEAN (WGHT(F3.2)) 
STDDEV (WGHT(F3.2)) RANGE (WGHT(F3.2)) 
PTILE 5 (WGHT(F3.2)) PTILE 10 (WGHT(F3.2)) 
PTILE 25 (WGHT(F3.2)) PTILE 50 (WGHT(F3.2))
PTILE 75 (W3HT(F3.2)) PTILE 90 (WGHT(F3.2))
PTILE 95 (WGHT(F3.2))
Programme 6: SPSSX programme to calculate statistics 
for "all multiparae" in QMH Group 1 (as 
defined on p 40 ) for a/ male infants and 
b/ female infants.
3.3 RESULTS
3.3.1 Effect of sex and parity on birthweight
Tables 1A, B & C (pp 44-46) present means, standard 
deviations and 5th, 10th, 25th, 50th, 75th, 90th, and 95th 
smoothed centile values of birthweight in kilograms for 
live births (QMH Group 1) classified according to sex and
parity. Of the very small number of births, from 28 weeks
till 32 weeks of gestation, the mean birthweights of male 
and female are fairly similar. However, and in common 
with other studies (Love & Kinch, 1965; Thomson et al,
1968), beyond 32 weeks males tend to be heavier than 
females, with the greatest difference in the mean 
birthweight (40 to 200 grams), occurring at 36-42 weeks 
(Table 1A) . The differences in mean birthweights between 
males and females at 36 to 42 weeks were confirmed by 
applying the t-test which was significant at t = 2.13, p < 
0.02; t = 2.42, p < 0.01; t = 5.96, p = 0.001; t = 3.50, p 
= 0.001; t = 8.12, p = 0.001; t = 7.36, p = 0.001; t = 
5.00, p = 0.001, respectively.
In addition, for an accurate estimation of the effect of 
sex on birthweight, a t-test was performed on the 
difference between the mean birthweight of males and
females born to primiparae (Table IB), so as to control
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for the influence parity might have on birthweight. It
was found to be significant between 38 and 42 weeks of 
gestation at t = 3.84, p = 0.001; t = 3.39, p = 0.001; t = 
4.78, p = 0.001; t = 4.07, p = 0.001; t =3.46, p = 0.001, 
respectively.
To determine the impact of parity on birthweight, a t-test 
was performed on the difference between the mean 
birthweight of males born to primiparae and to multiparae 
(Tables IB & C) . It was significant between 36 and 42 
weeks of gestation at t = 3.55, p = 0.001; t = 1.88, p <
0.05; t = 3.53, p = 0.001; t = 3.65, p = 0.001; t =
9.04, p = 0.001; t = 6.78, p = 0.001; t = 2.54, p < 0.01,
respectively.
The distributions of induced and non-induced births 
displayed no systematic difference at any gestational ages 
except at the 37th week (t = 3.02, p < 0.001) (Table 3).
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Table 1* Means, standard deviations and smoothed
centiles of birthweight (Kg), QMH Group 1
(A)
Males - All pregnancy numbers
WKS N MEAN SD PERCENTILES
5 10 25 50 75 90 95
28 8 1.19 0.14 0.93 0.94 0.12 1.21 1.28 1.38 1.39
29 6 1.40 0.19 1.09 1.12 1.28 1.36 1.46 1.58 1.60
30 6 1.49 0.11 1.19 1.25 1.42 1.52 1.65 1.78 1.82
31 12 1.65 0.28 1.24 1.34 1.54 1.71 1.90 2.05 2.14
32 25 1.97 0.40 1.31 1.44 1.70 1.93 2.17 2.35 2.50
33 39 2.12 0.39 1.45 1.60 1.89 2.15 2.39 2.57 2.79
34 39 2.35 0.34 1.64 1.80 2.07 2.34 2.57 2.76 3.01
35 83 2.44 0.41 1.83 2.00 2.26 2.53 2.77 3.00 3.22
36 132 2.77 0.46 2.02 2.19 2.49 2.77 3.03 3.31 3.48
37 282 3.01 0.49 2.26 2.41 2.73 3.01 3.28 3.59 3.75
38 701 3.22 0.44 2.50 2.65 2.93 3.22 3.50 3.80 3.98
39 1148 3.40 0.44 2.70 2.85 3.12 3.39 3.69 3.98 4.17
40 1521 3.54 0.43 2.85 3.02 3.26 3.54 3.85 4.13 4.30
41 930 3.67 0.45 2.95 3.12 3.33 3.65 3.97 4.23 4.37
42 251 3.81 0.42 3.00 3.15 3.34 3.68 4.01 4.26 4.37
Females - All pregnancy numbers
WKS; n MEAN SD
28 2 1.18 0.44
29 6 1.42 0.27
30 4 1.52 0.52
31 7 1.70 0.31
32 25 1.83 0.31
33 29 2.02 0.42
34 25 2.25 0.42
35 55 2.40 0.54
36 109 2.64 0.49
37 256 2.91 0.47
38 666 3.09 0.43
39 1133 3.26 0.43
40 1391 3.41 0.44
41 955 3.53 0.42
42 222 3.61 0.46
5 10 25
0.87 0.87 0.87
0.95 0.95 1.11
1.02 1.05 1.30
1.,08 1.19 1.48
1,.14 1.35 1.65
1.,27 1.50 1.80
1.48 1.64 1.94
1.68 1.82 2.12
1.88 2.05 2.35
2.12 2.32 2.60
2.37 2.55 2.80
2.57 2.74 2.97
2.73 2.87 3.12
2.,86 2.97 3.23
2.99 3.07 3.32
PERCENTILES 
50 75 90 95
1.18 1.49 1.49 1.49 
1.37 1.67 1.76 1.76 
1.53 1.84 1.98 1.98 
1.69 1.98 2.13 2.13
1.86 2.11 2.30 2.30 
2.04 2.29 2.55 2.56 
2.21 2.50 2.83 2.88 
2.41 2.72 3.07 3.18 
2.64 2.94 3.27 3.43
2.87 3.17 3.46 3.64 
3.07 3.37 3.65 3.83 
3.25 3.54 3.82 3.99 
3.39 3.68 3.97 4.13 
3.48 3.79 4.07 4.21 
3.55 3.87 4.13 4.23
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Table 1: (contd.)
(B)
Males - Primigravidae
WKS N MEAN SD PERCENTILES
5 10 25 50 75 90 95
28 6 1.15 0.13 0.94 0.93 1.10 1.18 1.24 1.35 1.32
29 5 1.42 0.21 1.10 1.09 1.22 1.36 1.44 1.51 1.49
30 3 1.45 0.14 1.20 1.20 1.31 1.51 1.61 1.66 1.65
31 4 1.51 0.22 1.23 1.29 1.44 1.68 1.86 1.88 1.92
32 12 1.94 0.43 1.26 1.45 1.64 1.90 2.19 2.21 2.28
33 15 2.17 0.40 1.37 1.68 1.86 2.12 2.46 2.52 2.57
34 22 2.31 0.36 1.58 1.87 2.05 2.26 2.60 2.74 2.78
35 41 2.37 0.38 1.77 1.97 2.20 2.40 2.74 2.97 3.04
36 67 2.64 0.46 1.94 2.12 2.39 2.61 2.95 3.23 3.33
37 113 2.88 0.42 2.17 2.35 2.61 2.87 3.19 3.47 3.62
38 265 3.17 0.43 2.43 2.60 2.83 3.11 3.40 3.66 3.87
39 493 3.30 0.42 2.64 2.78 3.03 3.29 3.58 3.82 4.04
40 706 3.44 0.40 2.79 2.93 3.17 3.46 3.75 3.99 4.17
41 445 3.57 0.43 2.89 3.05 3.25 3.59 3.89 4.12 4.27
42 152 3.76 0.40 2.97 3.11 3.27 3.64 3.94 4.17 4.31
Females - Primigravidae
WKS N MEAN SD PERCENTILES
5 10 25 50 75 90 95
29 2 1.32 0.43 0.99 1.02 0.99 1.32 1.63 1.63 1.63
30 3 1.57 0.62 1.01 1.05 1.04 1.51 1.80 1.87 1.88
31 3 1.44 0.26 1.05 1.13 1.18 1.66 1.94 2.04 2.10
32 12 1.73 0.40 1.10 1.26 1.41 1.83 2.06 2.19 2.34
33 14 2.02 0.39 1.18 1.44 1.63 2.01 2.20 2.34 2.61
34 11 2.06 0.38 1.30 1.62 1.83 2.19 2.39 2.58 2.92
35 32 2.40 0.58 1.48 1.79 2.05 2.40 2.63 2.90 3.25
36 58 2.64 0.51 1.74 2.00 2.30 2.63 2.88 3.18 3.49
37 105 2.81 0.46 2.02 2.24 2.55 2.84 3.10 3.39 3.65
38 258 3.04 0.43 2.30 2.46 2.76 3.02 3.30 3.58 3.78
39 485 3.21 0.41 2.52 2.66 2.92 3.18 3.47 3.74 3.91
40 593 3.33 0.43 2.70 2.82 3.05 3.32 3.60 3.88 4.03
41 467 3.46 0.40 2.84 2.94 3.18 3.43 3.72 4.00 4.10
42 138 3.59 0.45 2.98 3.04 3.30 3.52 3.84 4.09 4.14
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Table 1: (contd.)
(C)
Males - Multiparae
WKS N MEAN SD
5 10
28 2 1.32 0.08 1.26 1.26
29 1 1.34 * 1.31 1.31
30 3 1.53 0.08 1.35 1.36
31 8 1.72 0.29 1.39 1.42
32 13 2.00 0.37 1.43 1.50
33 24 2.09 0.38 1.52 1.63
34 17 2.40 0.32 1.69 1.83
35 42 2.51 0.42 1.91 2.07
36 65 2.91 0.43 2.14 2.31
37 169 3.10 0.51 2.34 2.52
38 436 3.25 0.45 2.55 2.72
39 655 3.48 0.45 2.77 2.93
40 815 3.63 0.44 2.94 3.10
41 485 3.76 0.45 3.00 3.15
42 99 3.90 0.45 3.00 3.15
Females - Multiparae
WKS N MEAN SD
5 10
28 2 1.18 0.44 0.93 0.87
29 4 1.47 0.23 1.23 1.23
30 1 1.37 * 1.45 1.48
31 4 1.90 0.17 1.57 1.63
32 13 1.92 0.16 1.63 1.72
33 15 2.01 0.47 1.66 1.76
34 14 2.40 0.40 1.66 1.80
35 23 2.40 0.49 1.74 1.93
36 51 2.64 0.47 1.93 2.15
37 151 2.98 0.46 2.20 2.40
38 408 3.13 0.42 2.46 2.62
39 648 3.30 0.44 2.64 2.79
40 798 3.48 0.43 2.78 2.92
41 488 3.59 0.42 2.90 3.02
42 84 3.63 0.47 3.05 3.12
PERCENTILES
25 50 75 90 95
1.26 1.31 1.37 1.37 1.35
1.34 1.39 1.45 1.46 1.44
1.42 1.55 1.64 1.69 1.68
1.53 1.75 1.90 2.04 2.07
1.70 1.95 2.15 2.38 2.49
1.93 2.15 2.36 2.60 2.80
2.16 2.36 2.56 2.79 3.03
2.38 2.61 2.80 3.05 3.30
2.61 2.87 3.07 3.37 3.62
2.82 3.10 3.34 3.66 3.90
3.01 3.29 3.57 3.87 4.10
3.18 3.46 3.76 4.04 4.27
3.34 3.62 3.92 4.20 4.42
3.43 3.71 4.03 4.34 4.48
3.45 3.75 4.13 4.43 4.49
PERCENTILES
25 50 75 90 95
0.92 1.18 1.49 1.49 1.49
1.23 1.35 1.58 1.63 1.63
1.48 1.55 1.73 1.80 1.80
1.65 1.77 1.93 2.00 2.02
1.76 1.97 2.14 2.25 2.29
1.86 2.14 2.36 2.56 2.63
1.98 2.31 2.58 2.87 2.97
2.16 2.48 2.78 3.11 3.20
2.38 2.66 2.99 3.31 3.40
2.63 2.89 3.20 3.51 3.63
2.84 3.10 3.39 3.70 3.86
3.02 3.29 3.58 3.87 4.05
3.16 3.45 3.74 4.01 4.19
3.26 3.55 3.86 4.12 4.23
3.31 3.60 3.92 4.18 4.23
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Table 2: deans, standard deviations and smoothed
centiles of birthweight (Kg), QMH Group 2
(A)
Males - All pregnancy numbers
WKS N MEAN SD PERCENTILES
5 10 25 50 75 90 95
28 4 1.17 0.20 0.93 0.93 1.01 1.17 1.32 1.38 1.38
29 4 1.37 0.23 1.11 1.12 1.17 1.33 1.47 1.55 1.55
30 1 1.51 * 1.24 1.30 1.32 1.52 1.63 1.72 1.74
31 3 1.63 0.31 1.35 1.45 1.46 1.73 1.85 1.93 2.03
32 11 1.90 0.35 1.48 1.59 1.63 1.94 2.09 2.18 2.44
33 13 2.12 0.33 1.68 1.75 1.83 2.12 2.33 2.43 2.81
34 13 2.37 0.31 1.88 1.90 2.06 2.31 2.58 2.72 3.07
35 26 2.54 0.44 2.02 2.06 2.29 2.54 2.85 3.07 3.28
36 48 2.82 0.47 2.17 2.25 2.53 2.82 3.12 3.39 3.50
37 102 3.09 0.45 2.38 2.49 2.76 3.08 3.36 3.62 3.73
38 272 3.26 0.41 2.58 2.71 2.96 3.27 3.55 3.81 3.96
39 476 3.41 0.45 2.74 2.89 3.13 3.41 3.72 4.00 4.16
40 642 3.56 0.42 2.89 3.05 3.28 3.54 3.85 4.14 4.30
41 354 3.68 0.43 3.03 3.19 3.40 3.64 3.92 4.18 4.34
42 73 3.80 0.44 3.10 3.24 3.44 3.67 3.92 4.16 4.30
Females - All pregnancy numbers
WKS N MEAN SD
5 10
28 1 0.87 * 0.91 0.87
29 4 1.31 0.25 1.09 1.09
30 1 1.37 * 1.22 1.26
31 2 1.68 0.01 1.29 1.41
32 7 1.75 0.46 1.30 1.52
33 11 1.90 0.41 1.28 1.56
34 7 2.13 0.29 1.35 1.64
35 15 2.39 0.62 1.55 1.86
36 34 2.75 0.47 1.82 2.19
37 93 3.00 0.49 2.16 2.46
38 251 3.11 0.41 2.46 2.64
39 422 3.30 0.44 2.66 2.78
40 579 3.42 0.43 2.78 2.90
41 363 3.54 0.42 2.88 3.01
42 74 3.53 0.42 3.03 3.14
43 5 3.74 0.33 3.24 3.30
44 1 3.43 * 3.43 3.45
PERCENTILES
25 50 75 90 95
0.93 0.90 0.87 0.91 0.89
1.15 1.21 1.23 1.27 1.25
1.30 1.46 1.49 1.54 1.53
1.43 1.67 1.71 1.80 1.81
1.58 1.84 1.95 2.08 2.15
1.73 1.97 2.21 2.36 2.46
1.89 2.15 2.50 2.67 2.77
2.11 2.41 2.84 3.01 3.12
2.38 2.70 3.11 3.31 3.44
2.64 2.93 3.30 3.52 3.68
2.85 3.11 3.44 3.69 3.88
3.00 3.27 3.57 3.86 4.05
3.13 3.40 3.68 3.97 4.17
3.24 3.48 3.73 4.01 4.21
3.33 3.51 3.73 3.99 4.18
3.41 3.51 3.71 3.93 4.03
3.45 3.51 3.66 3.83 3.78
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Table 2: (contd.)
(B)
Males - Primigravidae
WKS1 N MEAN SD PERCENTILES
5 10 25 50 75 90 95
28 2 1.01 0.12 0.93 0.93 0.93 1.01 1.13 1.10 1.12
29 3 1.38 0.28 1.15 1.14 1.21 1.36 1.62 1.68 1.68
32 5 1.79 0.39 1.41 1.41 1.52 1.71 2.01 2.16 2.15
33 4 2.03 0.32 1.70 1.70 1.82 2.01 2.32 2.53 2.52
34 7 2.45 0.35 1.91 1.94 2.07 2.23 2.56 2.83 2.85
35 11 2.42 0.31 2.02 2.07 2.26 2.41 2.77 3.09 3.13
36 19 2.63 0.45 2.12 2.21 2.44 2.62 2.98 3.29 3.37
37 32 2.92 0.36 2.26 2.40 2.67 2.90 3.20 3.48 3.62
38 88 3.20 0.46 2.44 2.60 2.89 3.14 3.41 3.66 3.89
39 189 3.28 0.42 2.63 2.76 3.05 3.31 3.59 3.87 4.10
40 270 3.46 0.41 2.81 2.92 3.19 3.47 3.76 4.04 4.22
41 155 3.60 0.44 2.98 3.05 3.31 3.59 3.88 4.11 4.24
42 48 3.72 0.40 3.10 3.12 3.35 3.63 3.92 4.09 4.21
Females - Primigravidae
WKS; N MEAN SD PERCENTILES
5 10 25 50 75 90 95
29 2 1.32 0.43 1.16 1.15 1.02 1.33 1.63 1.63 1.62
31 1 1.69 * 1.20 1.19 1.27 1.61 1.78 1.84 1.84
32 6 1.72 0.49 1.24 1.23 1.47 1.80 1.95 2.07 2.06
33 8 1.83 0.41 1.28 1.31 1.65 1.91 2.11 2.30 2.29
34 3 2.04 0.07 1.38 1.51 1.84 2.02 2.33 2.60 2.64
35 9 2.20 0.62 1.58 1.84 2.06 2.28 2.68 2.99 3.12
36 11 2.84 0.56 1.82 2.15 2.31 2.65 3.05 3.31 3.53
37 31 2.93 0.48 2.07 2.35 2.55 2.93 3.29 3.50 3.75
38 83 3.01 0.42 2.35 2.51 2.75 3.08 3.42 3.65 3.88
39 157 3.26 0.46 2.58 2.67 2.91 3.20 3.53 3.81 4.01
40 227 3.33 0.40 2.73 2.80 3.04 3.33 3.63 3.94 4.10
41 155 3.47 0.42 2.86 2.92 3.16 3.43 3.69 3.98 4.13
42 40 3.54 0.45 3.06 3.11 3.29 3.47 3.71 3.95 4.07
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Table 2: (contd.)
(C)
Males - Multiparae
WKS; N MEAN SD
5 10
28 2 1.32 0.08 1.27 1.26
29 1 1.34 * 1.32 1.31
30 1 1.51 * 1.39 1.38
31 3 1.63 0.31 1.50 1.49
32 6 1.99 0.32 1.61 1.61
33 9 2.16 0.35 1.72 1.75
34 6 2.28 0.27 1.83 1.93
35 15 2.61 0.50 1.95 2.14
36 29 2.94 0.46 2.13 2.36
37 70 3.16 0.47 2.38 2.58
38 184 3.29 0.39 2.61 2.77
39 287 3.50 0.45 2.79 2.95
40 372 3.63 0.41 2.97 3.11
41 199 3.75 0.42 3.16 3.26
42 25 3.96 0.49 3.33 3.37
PERCENTILES
25 50 75 90 95
1.28 1.30 1.36 1.36 1.36
1.32 1.38 1.42 1.42 1.42
1.40 1.52 1.58 1.60 1.60
1.54 1.72 1.82 1.96 1.96
1.69 1.93 2.09 2.37 2.37
1.85 2.13 2.33 2.69 2.71
2.04 2.35 2.59 2.95 3.07
2.31 2.62 2.90 3.22 3.47
2.61 2.91 3.20 3.48 3.75
2.86 3.15 3.43 3.69 3.90
3.05 3.32 3.61 3.88 4.03
3.21 3.47 3.77 4.05 4.20
3.34 3.59 3.92 4.21 4.35
3.41 3.71 4.09 4.34 4.43
3.44 3.91 4.27 4.43 4.45
Females - Multiparae
WKS N MEAN SD PERCENTILES
5 10 25 50 75 90 95
28 1 0.,87 * 0.93 0.93 0.92 0.88 0.87 0.87 0.87
29 2 1.,30 0.01 1.23 1.23 1.23 1.19 1.18 1.18 1.18
30 1 1.,37 * 1.47 1.47 1.47 1.45 1.42 1.42 1.42
31 1 1.,68 * 1.62 1.62 1.62 1.68 1.67 1.67 1.67
32 1 1.,93 * 1.70 1.70 1.73 1.91 1.99 1.99 1.99
33 3 2.,08 0.43 1.72 1.72 1.85 2.13 2.33 2.36 2.36
34 4 2.20 0.38 1.77 1.77 2.00 2.35 2.63 2.74 2.74
35 6 2.,67 0.55 1.91 1.93 2.22 2.60 2.90 3.08 3.11
36 23 2.70 0.42 2.16 2.21 2.46 2.79 3.11 3.35 3.44
37 62 3.,03 0.50 2.41 2.49 2.69 2.96 3.26 3.54 3.70
38 168 3..16 0.40 2.59 2.68 2.89 3.13 3.41 3.71 3.92
39 265 3.,33 0.44 2.71 2.84 3.05 3.30 3.59 3.86 4.08
40 352 3,.48 0.43 2.82 2.97 3.18 3.43 3.72 3.97 4.18
41 208 3.,60 0.42 2.93 3.08 3.27 3.49 3.82 4.04 4.21
42 34 3..53 0.38 3.10 3.19 3.31 3.50 3.95 4.10 4.19
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Table 3: Birthweight means and standard deviation by 
gestational age for cases (all women with 
an induced male births) and controls (all 
women with non-induced male births)
Group Week Number Mean
Standard
Deviation
32 2 2.35 0.52
33 2 1.72 0.44
34 2 2.59 0.19
35 12 2.38 0.54
36 25 2.63 0.62
Cases 37 45 2.82 0.47
38 115 3.15 0.51
39 164 3.39 0.47
40 269 3.58 0.47
41 246 3.68 0.45
42 99 3.83 0.40
32 26 1.97 0.39
33 37 2.14 0.38
34 39 2.33 0.34
35 71 2.45 0.39
36 109 2.80 0.41
Controls 37 239 3.05 0.48
38 597 3.23 0.43
39 998 3.40 0.44
40 1271 3.53 0.42
41 697 3.67 0.45
42 157 3.81 0.43
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3*3*2 Comgarison_with other standards
Tables 4 & 5 compare the 10th centile values of
birthweight for QMH Group 1 and 2 for males and females 
with similar values derived from four studies based on the
Scottish population. The Aberdeen centiles are those
reported by Thomson and associates (1968) in their 
analysis of 46,703 births which occurred between 1948 and 
1964 in the city of Aberdeen. The centile values reported 
by Cole (1981) were based on data derived from the 
Scottish neonatal discharge record, SMRll, on 
approximately 169,631 babies amounting to 40% of all 
live births in Scotland occurring between 1973 and 1979. 
The Glasgow standard (Forbes and Smalls, 1983) was
estimated using data from the SMR2 maternity discharge 
records relating to 55,387 births to women resident in the 
Greater Glasgow Health Board area during 1975-79. The 
Scottish Standard (Forbes and Small, 1982) was obtained 
from the Scottish Maternity Discharge Record SMR2 relating 
to 303,056 births from 1975-79.
Comparison between the figures of QMH Group 1 and 2 (Table
4) shows that the centile values of QMH Group 2 are 
generally greater throughout the gestational weeks, with 
the largest difference occurring at 32 weeks of gestation 
(150 grams). The QMH Group 1 centile values are generally
- 51 -
higher, later in pregnancy, than those recorded for 
Scotland (1973-79), Glasgow (1975-79) and Scotland (1975- 
79), with the largest differences occurring at 40-42 weeks 
gestation (70-130 grams; 120-160 grams and 100-140 grams) 
respectively. The Aberdeen centile values tend to be 
greater between 33-38 weeks, but beyond 38 weeks they are 
lower than QMH Group 1. The greatest difference is 140 
grams at 42 weeks. QMH Group 2 centile values are greater 
than almost all of the other standards. They are greater 
than those for Scotland (1973-79) with the largest 
differences occurring at 32-33 weeks of gestation (220-200 
grams), for Scotland (1975 -79) at 32-42 (260-230 grams), 
and for Glasgow (1975-79) at 33-42 weeks of gestation 
(230-250 grams). Although the Aberdeen centile values are 
greater between 33-37 weeks, beyond 38 weeks the QMH Group 
1 and 2 values are greater with a difference of 140 and 
230 grams at 42 weeks respectively.
In general the figures in table 4 closely resemble those 
in table 5. Throughout gestational weeks the centile 
values of QMH Group 2 are greater than QMH Group 1 with 
the largest difference at 32 weeks (170 grams). At many 
gestational ages, particularly after 37 weeks, the 10th 
centile values of QMH Group 1 are greater than those 
recorded for Scotland (1973-79), Scotland (1975—79) and 
Glasgow (1975-79) with the largest differences at 42 weeks
- 52 -
(160 grams; 180 grams and 220 grams respectively). 
Similarly the QMH Group 2 centile values stay greater than 
those of Scotland (1973-79), Scotland (1975-79) and 
Glasgow (1975-79) , with the largest differences at 42
weeks of gestation (20-30 grams; 30-30 grams and 90-70 
grams respectively). Beyond 38 weeks QMH Group 1 and 2 
centile values are greater than Aberdeen centile values 
with the largest differences at 42 weeks (290 and 220 
grams respectively).
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3.3.3 Comparison with the Scottish standard 1975-79 
(Forbes & Smalls, 1982)
Comparison of the 10th centile values of the QMH groups 
with those based on Scottish population (Forbes & Smalls, 
1982), shows that, beyond 38 weeks of gestation, the QMH 
centile values are higher than the Scottish (Tables 4 &
5) . The difference was confirmed statistically by a chi- 
square test which was significant at the 95% level of 
confidence except for few isolated cases (Table 6) . 
Similarly, beyond 35 weeks of gestation the 10th centile 
lines of QMH curves (figures 16-27) are constantly 
parallel and above the Scottish lines.
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3.3.4 Centiles growth curves for the QMH 1985-87
Figures 16-27 present curves of the 5th, 10th, 50th, 90th 
and 95th smoothed centiles of the distribution from 28th 
to 42nd weeks, for the QMH subgroups (1-12), super-imposed 
on the Scottish centiles curves (Forbes & Smalls, 1982). 
All QMH lines (5th, 10th, 50th, 90th, 95th) are evenly
distributed with gestational age except between 28 to 3 5 
weeks where fluctuations occur due to a small sample size. 
The 50th centiles lines are changing smoothly with 
gestational age. As can be seen by comparing QMH lines 
with those of the Scottish, between 35 to 38 weeks of 
gestation, the QMH lines are consistently parallel to the 
Scottish lines and beyond 38 weeks of gestation they are 
markedly above the Scottish lines.
- 58 -
G G H  H  «H i—I rH
•H ’H *rl *H *H *H *H
H  H  4J +J +J +J 4J
h  s:o co jG £ X! £ xi
co to +j +j +j -p +j
U  10 o  o  o  in
<7> <?> ID <H
• H
a  fa O  PQ O  OS
-- O
o
o
ro
r* pffl U 11
S .2
CM
ro
co o
o
m._ l.+«i  ^  a).- cnjc-4-* —  c cn
<3) 0 
C £5 
•H *H
(D (U <l> <D (U 
H  iH  pH H  ■HH *H •H *H
A 45 45 45 45
4-J +j 4J 4J 4J
in o o o in
<7» in h
0 y
2S Q N H  fn 0) H
a fa o a o os m
- -  l O
o
o
Tf-
co
to ^  
a) 
cu 
£
- o
s i
CO
a)
O
m
oi
m
o
o
to
•
co r**
0) QQ
£ 1
M m
0 CO
Dm Cfi
w  H
<n co
0
I >in H
r- 3 CO
<?> y cd
rH •H
h  y
fQ Ca 0< ftS(0 3  I
H 0 &4J M y0 0 My ftw B
E  H
M O H0 <
<u y
45 1
CO <M
y CO
> ^  a)
M H
3 •H (0y $ B
y
XI V  Dm
4J y
§ u0 (0
u a
&  a
y y
H
•H
+J (N
a oo
y
u  H
•
r-
H
CN
n
CO o
o
m — $ <!)._ OIC-m —  C JX. CP
C S5 rH rH rH rH rH
•H *H ’H *H *H ’H -H
H  H  4-J +j 4-) 4-> 4J
rH
o ui si £  si ja siW <0 -M -M -P A-» -P
'O m  o o o  in
on on in h
• H
a  ^  o m o & n
O
o
ro
wH
Pm cn
o o tn
CNJ
ro
(O Oo
rp. L-H-'JC ^  cd.— cnc-H •— ^
<DH
•rH
P
G<y
u
eC
o
6 M 
U
V  (3
0) rH
& m
O
o
Tt-
LO
h-
ro
O
in
ro
co
0
0
£
c
o
0
0
o
m
C'j
m
o
o
m
*
to
H
H
l
UJ •
to t"
00
M in
0  oo
Bm *
H
m (0
<D
\ >
in M
r " 3
Oh o  a)
H (3
H  'O
13 •H
£ Of >
(3 3  (3
H 0  Mp P 31
0  O  *H
0 -  RC/5
£  U
m a  Oj
0
P d) 1
45
to P  to
0) <U
H P  <3
3 'H  0
0 > 0)
h
JG V
P <u
I u
0 (3
M a
Cn 0
0
CD u
H
•H
P  CN
a oo
o) cr>
U  H
•
H
(!)
CM
rn
CD
H-
O
o
0 0 0) 0) 0 0 0
g a H H H H H
■H • H • H • H • H • H •rH
H P P P P P
G G G G GV V 0) 0 0 0 0
■H 0) u 0 U U 0
H  42
0 CQ 42 42 42 42 42to (0 +J P P P P
T 3i n  o  o  o  i n
<r> i n
© e © © © © e
to
© f H © © © © e
H
fO
pH e © © © © e72
a
3 <3 © © 9 © e
0
M to 0)
O CD Cn © G © M
£ G <y 0 u
f f i td 3 0 *0 tds 0 N  H M 0 H
a  h O  CQ 0  &  32
o
o
LO
ro
o
inro
CO
a)
CD
£
co
CO
CD
o
in
CNro
o
•o
m
CM
ro
co O
o
CD—  L.-M-C £  cd—  coc-f-» —  c cn
Fi
gu
re
 
2
0
. 
Ce
nt
il
e 
gr
ow
th
 
cu
rv
es
 
fo
r 
Sc
ot
la
nd
 
19
75
-7
9 
(F
or
be
s 
& 
Sm
al
ls
 
19
82
) 
co
mp
ar
ed
 
wi
th
 
th
e 
QM
H 
Gr
ou
p 
1 
cu
rv
es
 
19
85
-8
7.
Ma
le
s 
- 
Mu
lf
ip
ar
ae
G C rH rH rH rH rH
•H *H *H *H tH *H *H
H  rH 4J +J 4J 4J 4J
rH 43
0 m 43 43 43 43 4:ui id +j -P +j +j +j
'Oinooom in H
b a> cn • c • m
UK u ro 3 a v <dZ O U H  p  Q) H
a h o cq o cs n
-•
w r-*
a> 00
0 • •P 1M tn
0
M*
0 oo
' H
^ w
O ^ S w
inro
c
to
-M
«J3
0
H—1
CO
CD £ T3
O H E
10
CM
0 3
& fOro 0) u
H
O
oro
CM
ro
co
H-
O
o
m —  l_-r->JC S  <U._ DU=-m  c -* cn
C f3 rH fH fH H H
•H *H »H *r| *H *H -HH H p p p p 4J
C C c  c  cTJ T3 <D 0) <U 0 <y
® H
O 0) tn 8 fi 6 M
rQ  fi <U 0) U
tn ^ rd d a) t) (0
S  0  P H  M <D H
cx fa o cp o & n
H-
CN
ro
- m
o
o
N-
wro
<D
%
~  o
in §  
ro
co
CD
O
m
CN
ro
o
o
ro
co
H-
O
o
*.
w
H
H
l
Uf
•
to
* 001U in
0 00
h  a*Srf* H
CTi to
h* 0)
1 >
m u
r*» d& 0 CO
fH <d
CM *H
•-a U
e a  c
d d  d
H 0 6P M tn
0 0  a>
0 u
w B &
u a  h
0 H
p 0)
42
CO P  l
0)
>  43 CO
H P  0)•H H
U >  d
£
43 •0
P a>
i M
0 du 0 .
t7> S
0
CD 0
H
•H
P  CN
e  00
<d
U  H
*
CM
CM
4>
CD.— OlC-4-» c CP
Q) CD 
C C 
•H -H
pH fH
-H <U 
H  £  
0 CO 
CO CO 
T3
0 0
cn
© ©
m
©
pH
« ©
CO
s pH © 0 © 0 ©
rH
CO
CM g 0 © © © ©
W
a
3 UJ © © © © ©
0
Sh CO 
O  CD
0)
to © C 0
rQ c CD 0) 0
ffi Sh co d 0) V (0
a o M H u CD rH
a  h o fflO  03 CQ
\
\
\
CD 0) (D CD 0) >H H H r-C pH 
•H *H -H *H *H 
P  P  P  P  P
c C c C C 
<D<D< D< U< U  
U U U U U
£ £ JZ £ JG 
p p  p p p
m o o o in
-- lO
O
-4-
CN
ro
co O
o
•H "H -H *H *H -H »H
H  H  4-> 4J +J 4J +J
g s e c gT3 'O Q) (U fl) fl) D
•H Q) U o u y u
H  JC
P  P  p  p
in o o o01 01 UD eH
e H
3  US
a fa o m o at
O
o
N-
in
CNro
o
oro
w
H
US
in
K  COro j*
CD
CD
£
CO
CD
o
W
01) 00
& 1u in
o  oo
fa Oft
H
cr» W
r* a)
s >
in M
3
01 u
iH 0)
CN fO
•0 ^ V§ 0t<*H
3 3  >
H 0  (0P M M
O O  01
0 •H
w
1  -H
m c k p  
o  &
ip 0)
43 1
(0 P
01)
>  £  <u
H P  H3 •H (TJ
u £  S
43 V
t 0)M0 fdu a
on a
0^ u
H
•H <*»S
P  CN
f i  00
<U Oi
a  h
#
CN
<U
•H
fa
CNI
ro
CO o
o
□a- <d . _  c n c -+ -»  —  c  c p
0 0 
H  H  
•H *H P P 
C C 0 0 
0 U
£ £2 
P  P  
O  LD
e ^
u'V 0 0 H 
& ffl
O
o
in
E :  w ro j*
CD
I
- o
CO
CD
o
m
CNro
o
oro
•p «*
CM
ro
co Oo
m —
0 0) 0 0 CD 0 0
f i c H H rH rH H
•H •H •H •H •H •H •H
H H P P 4J p P
C C c c (3V V 0 0 CD 0 0
•H 0) u U O 0 u
H  jg
0 cn 43 43 43 rC £
0} cd P P p P
V m o o o i n
O'* 0^ LO rH
e 9 e e e 0
cn
• rH
rH
td
CN & 0 0 0 0
w
a
3 * c # « •
0
u cn 0)
o 0) &> c aM£ c CD 0 O
E 5»)cd 3 0 td 0s 0 M H 0  Ha fa O  CQ O  «  ffl
:
\
m
oro
o
inro
m
04ro
O
oro
wH
H
W
UJ
•
W
0 eo 
f 1U in 0 00 
Pm Ch
CO
CD
CD
£
co
CO
CD
O
CM
ro
CO Oo
^  CD—  OOC-h» C &
•H -H *H *H *H »H *H 
H H  .p 4J 4J .p
fH £
o m ^  ,c 43 JC &
0) (G p -p -P -p .p
T3 m o o o mCTl (T> m rH
O <D Oi • c • M
&  C <D <U U 
P <d 3 0) TD fd
S 0 M H  p 0 H
a fa o co o cs in
o
o
N"
in
03m  ^
CD
CD
£
-- o
CO
CD
o
m
CN
m
o
•o
m
CM
ro
CD o
o
CD—  UICh-» c cn
Fi
gu
re
 
2
7
. 
Ce
nt
il
e 
gr
ow
th
 
cu
rv
es
 
fo
r 
Sc
ot
la
nd
 
19
75
-7
9 
(F
or
be
s 
& 
Sm
al
ls
 
19
82
) 
co
mp
ar
ed
 
wi
th
 
th
e 
QM
H 
Gr
ou
p 
2 
cu
rv
es
 
19
85
-8
7.
Fe
ma
le
s 
- 
Mu
lt
ip
ar
ae
3.4 DISCUSSION
3.4.1 Effect of sex and parity on birthweight
The present study, in conformity with almost all previous 
investigations (Love & Kinch, 1965; Thomson et al, 1968), 
showed that birthweights by sex were practically identical 
at 28-33 weeks of gestation but then gradually diverged; 
males being heavier at term than females. This is possibly 
due to a sex hormone difference rather than to different 
growth potentials; testosterone for example is recognised 
as having a markedly stimulating effect on growth (Love & 
Kinch, 1965).
The present work showed that male infants born to 
multiparae were heavier than those born to primparae and 
was the same as those reported earlier (McKeown & Gibson, 
1951; Thomson et al, 1986; Milner & Richards, 1974; Forbes 
Sc Smalls, 1982)
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3.4.2 Fetal Growth Standards
General consideration
Appropriate fetal growth standards usually describe mean, 
standard deviation and percentile values of birthweight 
for each length of gestation subdivided by the sex, parity 
and maternal size. Some investigators (Lubchenco et al, 
1963) described the uses of common (all pregnancies, both 
sexes) standard only. But the matter is not so straight 
forward. Suppose that a common standard was used to study 
the effect of pre-eclampsia on birthweight. Any 
depression of fetal growth associated with pre-eclampsia 
would be exaggerated, because most cases of pre-eclampsia 
occur in first pregnancies, which have relatively low 
birthweight for gestation. In fact, a 'false positive' 
result might be obtained merely because of the association 
between pre-eclampsia and primiparity. In such
comparison, the use of parity-specific standards is 
essential. The same sort of problems would arise in any 
comparison which might imply differences of maternal 
height and weight; for example, a comparison between 
ethnic groups, social classes, or even different regions 
of a country. The effect of maternal size was not 
considered in this study because the relevant data was not 
available. Nevertheless, fetal growth standards of this
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study have given smoothed percentiles values of 
birthweight by gestation for all live born fetuses 
subdivided by sex and parity. These results are 
comparable with most previously published standards.
Comparison with other standards
Since 1968, Aberdeen standards have been widely adopted in 
Scotland and elsewhere. Clearly they are still appropriate 
in clinical and research applications if the population to 
which they are applied exhibits the same underlying 
pattern of fetal growth inherent in Aberdeen population. 
However, it may be reasonable to assume that the 
reproductive experience of the Aberdeen population was and 
remains different from that in both local population and 
the general Scottish population. As such, the differences 
in birthweight for gestational age standards reported in 
this study are, perhaps, not unexpected.
In this study, The QMH Group 1 and 2 standards were 
generally greater, later in pregnancy, than the previous 
Scottish standards and Aberdeen standards. The reasons for 
the discrepancies among the standards are complex. One 
possible explanation can be traced to differences in 
demographic, social, ethnic and environmental character 
istics of the population. Recent shifts in the maternal
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age, parity and social class distribution of births in 
Scotland (Baird, 1980; Forbes et al,1982) may explain some 
of the differences between the Aberdeen and Scottish 
standards. For example, the proportion of women in the 
Aberdeen sample who had three or more previous pregnancies 
was 35%, whereas since 1975 this proportion was only 7% in 
Scotland. The social class distribution of births has 
also changed with a relative increase in social class I 
and II births accompanied by a decline in social class IV 
and V births.
Improvements in obstetric care and changes in obstetric 
management and intervention over the past 10-20 years may 
have also affected the observed relation between 
birthweight and gestational age. One influence,
attributable to a number of factors including more 
effective obstetric care, is the decline in stillbirth 
rates at all birthweights. Improved chances of survival 
will increase the number of infants being included in the 
sample of live births and thus altering the centile curves 
of birthweight for gestational age. The overall effect of 
falling stillbirth rates on birthweight distribution 
appears to be greater between 28 and 36 weeks gestation 
where low birthweight infants predominate and the number 
of births are small whereas at 36-40 weeks the birthweight 
distribution of live births is largely independent of
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changes in stillbirth rate due to a large number of births 
at these gestational ages (Forbes & Smalls, 1983). 
Nevertheless, the improvements in obstetric care offer 
only a partial explanation for the observed differences 
between QMH Groups and the various growth standards.
Changes in obstetric practice in terms of the proportion 
of induced deliveries may also influence the relation 
between birthweight and gestational age. Induced
deliveries of infants with suspected growth retardation 
may tend to increase the number of "light" birthweight 
infants at short gestation and depress the corresponding 
birthweight distribution as growth retarded live born 
infants are redistributed from, say, 39 to 38 weeks 
gestation. This proposition was tested in this study and 
the distributions of induced and non-induced births 
displayed no systematic differences. It was only 
significant at the 37th week of gestation which may have 
occurred, most probably, by chance. These changes in 
obstetric practice thus appear to have no impact on the 
distribution of birthweight and provide no explanation for 
the greater centiles values of QMH Group 1 and 2, in which 
the percentage of non-induced labour were 82% and 100% 
respectively.
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Since the Scottish standard 1975-79 (Forbes & Smalls, 
1982) and that of the QMH Groupl (subgroups 1-6) are based 
on the analysis of all live singleton births with the 
exception that the QMH Groupl has included all women with 
an accurate ultrasound dating early in pregnancy, it is 
justifiable to consider the Scottish population as a 
control group. Having not forgotten the difference in the 
respective population sizes, nevertheless, the QMH 10th 
centile values are significantly higher later in pregnancy 
than the Scottish values. This finding could be 
attributed to the ultrasound dating early in pregnancy 
which is a routine at the time of first booking at the 
Queen mother's Hospital.
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3.5 Conclusions and Recommendations
The accurate assessment of fetal growth in a population 
requires growth standards ideally reflecting the pattern 
of growth and development characteristic of that 
population. This study provides local growth standards. 
Tables and curves are prepared, showing the mean, 
standard deviation and 5th, 10th, 25th, 50th, 75th, 90th
and 95th smoothed centile values of birthweight by
gestational age for each week of gestation from 28 to 42 
weeks, subdivided by sex of infant and parity of the 
mother. It appears that between 35 and 38 weeks of 
gestation, the 10th centile values of QMH groups are
comparable with those recorded for Scotland (1975-9), but 
beyond 38 weeks of gestation, they are significantly 
higher.
The growth curves show that, between 35 and 38 weeks of
gestation, all centile lines (5th, 10th, 50th, 90th and
95th) are comparable with the Scottish centile lines 
(Forbes & Smalls, 1982), but beyond 38 weeks they are 
higher.
The study shows that sex of the baby and parity of the 
mother have an effect on the birthweight.
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Beyond 32 weeks of gestation male infants are heavier than 
females. Likewise infants of multiparae are heavier than 
infants of primiparae at most gestational ages.
The distributions of induced and non-induced births 
display no systematic differences and was only 
statistically significant at the 37th week of gestation.
Although the number of live births involved in this study 
was small, the results were encouraging as they were 
achieved by relying on groups of women with accurate 
ultrasound dating. This could be of great value in 
improving the accuracy of the growth standard. Therefore, 
further studies based on a large population of live births 
born to women with accurate ultrasound dating early in 
pregnancy would be ideal for a growth standard.
It is hoped that the QMH centile values will prove useful 
in monitoring birthweights of infants born in the QMH.
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CHAPTER 4 
INTRAUTERINE GROWTH RETARDATION
4. INTRAUTERINE GROWTH RETARDATION
4.1 Introduction
Intrauterine growth retardation is the term applied to an 
infant whose growth as a fetus was less than expected 
(Chudleigh & Pearce, 1986). One criterion for identifying 
these infants is the birthweight centile (Deter et al, 
1982), and end-points on or below the 10th, 5th or 3rd 
centiles have been used to define small for gestational 
age (SGA) babies who are at increased risk of being growth 
retarded (Chudleigh & Pearce, 1986) and have been shown to 
have a high incidence of somatic and intellectual sequelae 
(Commey & Fitzhardinge, 1979). IUGR is commonly used 
incorrectly as an interchangeable term with SGA. Not 
all SGA fetuses are cases of IUGR. For example, most 
cases of symmetrical IUGR (in which there is symmetrical 
reduction in the size of all organs) have no demonstrable 
cause and probably represent the lower end of the normal 
range. These infants should not, therefore, be looked 
upon as growth retarded. On the other hand, not all cases 
of IUGR are SGA. For instance, if the infant was 
genetically" programmed" to be 4.5 kg at delivery and was 
only 3.7 kg it would not be SGA but would be growth 
retarded and could be expected to have all the problems 
associated with IUGR (Chudleigh & Pearce, 1986).
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4.1.1 Intrauterine growth retardation and fetal mortality 
and morbidity
The intrauterine growth retarded infant is at greater 
risk of perinatal death , neonatal morbidity and long 
term physical and mental handicap (Lubchenco et al, 1963; 
Van den Berg & Yerushalmy, 1966; Fitzhardinge & Steven et 
al, 1972). In studies of perinatal mortality conducted 
both in this country and abroad, it has been found that a 
sizable proportion of perinatal loss is associated with 
IUGR. The report of Forbes and associates (1982) of the 
perinatal mortality in Scotland; 1970-1979, showed a high 
rate of perinatal mortality in low birth weight infants. 
The Scottish perinatal mortality survey for 1977 showed 
that 34% of perinatal deaths in singleton pregnancies 
occurred in association with IUGR in the absence of fetal 
abnormality, maternal diseases and other complications of 
pregnancy. The majority of these deaths occurred in 
utero; 45% occurred after the 36th week and most of these 
could probably have been prevented by planned early 
delivery had the diagnosis of growth retardation been 
established in time (Mcllwaine et al, 1979). To reduce 
perinatal mortality, morbidity and long term handicap, 
there is thus a vital need for an effective method of 
detecting such fetuses early enough to permit intensive 
monitoring of fetal wellbeing during the last months of
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pregnancy and during labour upon which decisions on 
optimal timing and mode of delivery should be based 
(Brook, 1983).
4.1.2 Types of intrauterine growth retardation
It is recognized that babies with IUGR are not a 
homogenous population and that at least two morphological 
groups can be distinguished: one in which there is
symmetrical reduction in the size of all organs 
(symmetrical growth retardation) and the second in which 
the baby has a long wasted body and a relatively large 
brain which has been preferentially protected from the 
full effects of the growth retarding mechanism 
(asymmetrical growth retardation). The aetiological 
mechanisms, perinatal risks and long term prognosis appear 
to differ between the two groups (Campbell, 1974a).
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4.1.3 Aetiology of impaired intrauterine growth
The aetiology of IUGR is complex, and will be considered 
in relation to three groups of factors (Hohler, 1985) 
(Fig.28): (1) Maternal (2) Placental (3) Fetal
Maternal
Disease UteroplacentalPoor Placental
InsufficiencyPerfusion
Primary
Placental
Pathology
Congenital
Fetal IUGRAnomaly or >
Infection
Figure 28: Categories of pathology that may lead to fetal 
IUGR are grouped into those that cause poor 
placental perfusion and those which cause 
primary anomalies, chromosomal abnormalities, 
or infection in the fetus.
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1. Maternal factors
Maternal disease states, such as severe diabetes mellitus, 
chronic hypertension, chronic renal disease, sickle cell 
disease, cyanotic heart disease and some collagen diseases 
such as systemic lupus erythematosus, can cause vascular 
damage in the uteroplacental bed leading to reduced 
placental perfusion, which, in turn deprives the fetus of 
oxygen and/or vital nutrients especially glucose. Such 
reduced placental support of the growing fetus is broadly 
termed "uteroplacental insufficiency" (UPI).
2. Placental factors
Placental abnormalities such as circumvallate placenta, 
chronic retroplacental bleeding, placenta praevia, 
placenta accreta, and placental infarction, can also lead 
to UPI, but this is not as common as decreased placental 
perfusion secondary to maternal vascular disease.
3. Fetal factors
Fetal abnormalities such as cardiac malformations, a 
variety of anomalies of the genitourinary and central 
nervous systems, as well as many chromosomal 
abnormalities, such as trisomies 13, 18, and 21, are
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frequently associated with IUGR. In addition, certain
congenital viral infections such as rubella or cytomegalic 
virus can also cause IUGR.
These factors can lead to two groups of growth retarded 
fetuses, some becoming symmetrically retarded others 
asymmetrically. In symmetrical retardation, occurring when 
there are intrinsic fetal abnormalities such as anomalies 
or infection, growth of the fetal head, the trunk, body 
length and all fetal organs are proportionately reduced 
compared with normal expected values. Measurement of 
various parts of the fetus will, therefore, show no change 
in the symmetry of the fetal body. Hence, this type of 
IUGR is called symmetrical or "low profile" type IUGR. On 
the other hand, intrauterine growth retardation caused by 
uteroplacental insufficiency affects various fetal organs 
at different rates and to varying degrees. This leads to 
an asymmetry of organ sizes. Hence, this type is called 
asymmetrical or "late flattening" type of IUGR (Campbell, 
1974).
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4.1.4 Detection of intrauterine growth retardation
Although various methods have been used for prenatal 
detection of intrauterine growth retarded fetuses, 
accurate detection remains difficult. Clinical techniques 
of fundal height measurement for its detection have been 
disappointing (Beazley & Underhill, 1970). Hall and 
associates (1980) reported only a 44% detection rate of 
growth retarded fetuses, while in another study Rosenberg 
and associates (1982) found a 50% unsuspected rate by 
clinical parameters in 226 growth retarded fetuses. Only 
73 of 226 were detected by palpation and 13 of 226 by poor 
weight gain. Ultrasonography with the ability to
visualize the fetus and measure fetal body parameters and 
growth has potential for detection of the growth retarded 
fetus.
The two types of IUGR may be recognized by serial 
ultrasonic measurements. A late flattening growth curve 
detected by serial measurement of the BPD reflects 
asymmetrical IUGR; the BPD is within the normal range 
until after 30 weeks of gestation when its rate of growth 
slows or stops and comparisons of head and trunk growth 
have revealed a disproportionate decrease in the latter 
(Campbell & Thoms, 1977; Crane & Kipta, 1979). The second 
type of growth retardation, i.e low profile or
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symmetrical, is characterized by a BPD that grows 
consistently slower than normal from as early as 20 
weeks, and comparisons of head and trunk growth have 
revealed a proportionate decrease in trunk growth 
(Campbell & Thoms 1977).
Over the years several fetal parameters have been measured 
with ultrasound in an attempt to detect IUGR. These 
include
1. Head (Biparietal diameter 'BPD'; head area ’HA1; head 
circumference 'HC1; cerebellar diameter ).
2. Trunk ( abdominal area 'AA'; abdominal circumference 
’AC’; thorax; liver; kidney; adrenal ).
3. Limb ( femur length 'FL'; tibia length 'TL1; feet ).
4. Other measurements ( crown rump length 1CRL1; total 
intrauterine volume 'TIUV1; qualitative amniotic fluid 
volume 'LV'; placental grading).
The choice of measurement depends on several factors, 
including the equipment, personnel and time available, in 
addition to fetal attitude and position.
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Since the introduction of diagnostic ultrasound in 
obstetrics, cephalometery has been used for the assessment 
of gestational age and fetal growth. BPD was the first to 
be intensively investigated, serial BPD measurements were 
first introduced by Willocks (1962b) as a means of 
detecting placental insufficiency. However it was useful 
in identifying only 60-70% of cases of IUGR. Other 
investigators have found that BPD alone was a poor 
indicator, with a detection rate of only (50-60%) (Queenan 
et al, 1976; Sabbaga, 1978). Kurjak and associates (1980) 
found that both single or serial BPD determinations 
showed only about a 50% positive diagnostic accuracy. 
These results are disappointing but not surprising because 
measurement of the head alone ignores brain sparing which 
lead to asymmetrical or late flattening type of IUGR that 
comprises two thirds of these cases.
The cerebellum, which is housed in the posterior fossa, 
represents an area of the brain that is easily visualized 
sonographically yet has been poorly studied. Early 
sonographic visualization of the cerebellum occurred as 
early as 10 to 11 weeks' gestation. The sonographic 
evaluation of cerebellar growth reveals a linear 
relationship during the second trimester, thus the 
measurements in millimetres are approximately equal to the 
gestational age in weeks during this period (Goldstein et
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al, 1987). It was found that the measurement of 
transverse diameter of cerebellum permits the estimation 
of gestational age independent of the shape of the fetal 
head or presentation of the fetus and also may offer more 
precise information regarding fetal growth than would bony 
measurement of the fetal head have offered (McLeary et al, 
1984; Goldstein et al, 1987). Reece and associates (1987) 
findings indicate that growth of the transverse cerebellar 
diameter is unaffected by IUGR, and this measurement 
represents a parameter that is not affected by alteration 
in fetal growth and therefore could be used as a standard 
for gestational age against which all other biometric 
parameters could be compared (Reece et al, 1987). At 
present assessment of head size alone, using BPD, HA or 
HC, has been recognized as inappropriate and superseded by 
ultrasonic measurement of fetal trunk.
Abnormalities of fetal trunk dimension should relate well 
to IUGR because animal and human studies have consistently 
shown severely reduced hepatic glycogen stores and liver 
mass with IUGR (Evans et al, 1983). The best predictor of 
intrauterine growth retarded fetus was the AC alone or in 
conjunction with HC in HC/AC ratio (Wittmann et al, 1979; 
Kurjak et al, 1980). The HC/AC ratio was first described 
in 1977 (Campbell & Thoms, 1977)) and was used to 
distinguish between symmetrical and asymmetrical IUGR,
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since a high ratio would be expected if the head was of 
normal size and the abdomen small because of reduced liver 
size. Taken in conjunction with other parameters, this is 
a useful measurement, but, alone it cannot be relied on 
since patterns of growth are so variable.
Femur length adds a relatively new easily reproducible 
measurement of the fetus that can be made throughout 
pregnancy. It has two important roles in relation to 
IUGR. It provides an antenatal measurement of length 
which can also be followed through postnatal life. 
Moreover, it defines another parameter for identifying 
symmetrical IUGR (Gregory, 1982).
As a further diagnostic possibility, ultrasonic 
measurement of total intrauterine volume (TIUV) has been 
advocated as a useful early predictor of IUGR (Gohari et 
al, 1977; Geirsson et al, 1985; Hobbins et al, 1987). 
Because of the necessity to use a contact B-Scanner, TIUV 
measurement has recently decreased in popularity (Grossman 
et al, 1982; Seed, 1984; Hohler, 1985). The qualitative 
assessment of amniotic fluid (amniotic fluid volume'LV') 
has been confirmed as a gestational age independent method 
for the detection of IUGR (Manning et al, 1981). The 
presence of a pocket of amniotic fluid less than 2.0 cm in 
depth is highly suggestive of SGA fetus. However, the
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presence of a pocket of amniotic fluid more than 2.0 cm 
does not guarantee an appropriate for gestational age 
fetus (Chamberlain et al, 1984a).
Subsequent work confirms that fetal growth is best 
assessed by a combination of two or more measurements. 
Wittman and associates (1979), followed by Neilson and 
associates (1980), compared head, abdominal and CRL 
measurements as predictors of IUGR. The product of CRL and 
AA gave a sensitivity of (94%) and a specificity of (90%) 
in predicting IUGR at 34-36 weeks. Other investigators 
suggested that FL/AC is the best indicator in the patients 
with inaccurate gestational dating (Vintzileos et al, 
1985).
The proper use of all these parameters, requires precise 
knowledge of the duration of gestation, which is unknown 
or unavaialable in 20-40% of the cases (Dewhurst & 
Campbell, 1972 ). When the last menstrual period is
unknown or uncertain, the use of a date-independent fetal 
parameter or ratio has been shown to be of great benefit 
(Hadlock et al, 1983 ). Many studies have outlined the
roles of AC, FL/AC ratio, TL/AC ratio and qualitative 
determination of amniotic fluid volume as age independent 
indices in identifying intrauterine growth retarded fetus
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(Dewhurst & Campbell, 1972; Gohari et al, 1977; Vintzileos 
et al, 1985; Divon et al, 1986).
It was the main aim of this study to identify which single 
measurement or combination of measurements would best 
discriminate the growth retarded fetus, and to assess the 
predictive ability by evaluating the sensitivity, 
specificity, predictive value of positive and negative 
test, of these measurements throughout gestation. In 
addition the associations between IUGR and perinatal 
mortality and morbidity are studied.
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4.2 Patients and methods
4.2.1 Evaluation of the various ultrasound measurements
Applying programmes (7-15) on the computerised ultrasound 
and perinatal data bases, a total of 14791 measurements 
were obtained from 2810 women at 28 to 36 weeks 
gestation. All the women included in this group (group 1) 
had singleton pregnancies and had an ultrasound 
examination before 20 completed weeks of pregnancy to 
establish or confirm gestational age. They had a second 
examination at 28 to 36 weeks' gestation to assess fetal 
growth. For practical purposes of this thesis, birthweight 
below the 10th centile line on the Scottish birth weight 
for gestation nomogram (Forbes & Smalls, 1982) was used as 
a criterion to identify the growth retarded fetus. This 
work included some babies genetically predetermined to be 
small and whose intrauterine growth not subsequently 
retarded.
Seven different single ultrasound parameters and two pairs 
of combined measurements were evaluated for their ability 
to detect growth retarded fetuses (Table 7).
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Table 7: Nine ultrasound parameters
Biparietal diameter (BPD)
Head area (HA)
Head circumference (HC)
Abdominal area (AA)
Abdominal circumference (AC)
Femur Length (FL)
Amniotic fluid volume (LV)
Abdominal area x femur length (AAFL)
Abdominal circumference x femur length (ACFL)
The equipment used and measurement techniques were 
described in chapter 2 (para 2.2 & 2.3).
AAFL was calculated from the product of abdominal area and 
femur length and ACFL from the product of abdominal 
circumference and femur length. Values below the 10th 
percentile for the various measurements were used to 
indicate the possibility of a fetus being growth retarded 
and compared with a birth weight of less than 10th 
centile.
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Programmes 7-42:
Programmes 7-15: SPSSX programmes to calculate
sensitivity and specificity for BPD, 
HA, HC, AA, AC, FL, LV, AAFL & ACFL 
for a women with a singleton 
pregnancy and confirmed ultrasound 
date prior to 20 weeks, (group 1)
Programmes 16-24: Same as programmes 7-15, for 14 days
before delivery.
Programmes 25-33: Same as programmes 7-15, 7 days before
delivery, (group 2)
Programmes 34-42: Same as programmes 7-15, for 2 days
before delivery.
The following page shows programme 10 as an example of the 
programmes 7-15. This example relates to AA (group 1). 
Note the programmes use the variable names TA and TC 
(trunk area and trunk circumference) to denote the 
measurements of abdominal area(AA) and abdominal 
circumference (AC).
FILE HANDLE ALPHA / NAME = n :GOUA02.US85.SPFALLUM85"
FILE HANDLE BETA / NAME =" :GOUAl3.US86.SPFALLUM86"
FILE HANDLE GAMMA / NAME =" :GOUA07.US87.SPFALLUM87"
ADD FILES FILE =ALPHA / FILE =BETA / FILE =GAMMA 
SELECT IF TA GT 0
AND NOFETUSD EQ 1 AND US LE 200 AMD (WKSM GT 27 AND VJKSM LT 37)
(SELECTION REPEATED FOR 14 DAYS BEFOP. DELIVERY "TIMEDIFF LE 34",
7 DAYS BEFOR DELIVERY "TIMEDIFF LE 7" OR 2 DAYS BEFOP.
DELIVERY "TIMEDIFF LE 2")
SORT CASES BY QMHNO WKSM
MATCH FILES FILE = */BY = QMHNO / FIRST= FST/LAS1-LAST 
VARIABLE LABELS FST '1= FIRST RECORD FOR THIS PATIENT'
LAST '1= LAST RECORD FOR THIS PATIENT''
SELECT IF FST = 1 
COMPUTE TACT2 = 0 
MISSING VALUES TACT2 (0)
DO IF (WKSM = 15 )
RECODE TA (LO THRU 70.1 = 5)
( 70.2 THRU 71.9 = 10) ( 72.0 THRU HI = 11) INTO TACT2 
( 778.8 THRU 809.6 = 10)( 809.7 THRU HI = 11) INTO TACT2 
(PROCEDURE REPEATED FOR EACH WEEK, 15 THROU 43)
ELSE IF (WKSM = 43 )
RECODE TA (LO THRU 877.3 = 5)
( 877.4 THRU 877.4 = 10)( 877.5 THRU HI = 11) INTO TACT2
END IF
COMPUTE HUM = 1 
COMPUTE TP=0 
COMPUTE TN=0 
COMPUTE FP=0 
COMPUTE FN=0
DO IF (BWCT2 LE 10 AND TACT2 LE 10)
COMPUTE TP = 1 
END IF
DO IF (BWCT2 GT 10 AND TACT2 LE 10)
COMPUTE FP = 1 
END IF
DO IF (BWCT2 GT 10 AND TACT2 GT 10)
COMPUTE TN = 1 
END IF
DO IF (BWCT2 LE 10 AND TACT2 GT 10)
COMPUTE FN = 1 
END IF
SORT CASES BY WKSM
Programmes 7-42:
AGGREGATE OUTFILE = *
/ BREAK = NOFETUSD / SUMNUM SUMTP SUMFP SUMTN SUMFN = SUM (HUM TP F
COMMENT *** CALCULATE SENSITIVITY AND SPECIFICITY P TN FN ^
COMPUTE AB =* SUMTP + SUMFN 
DO IF (SUMTP = 0 AND SUMFN = 0)
COMPUTE AB = -1 
END IF
MISSING VALUES AB (-1)
COMPUTE SENS = SUMTP / AB
COMPUTE CD = SUMTN + SUMFP
DO IF (SUMTN = 0 AND SUMFP = 0)
COMPUTE CD = -1
END IF
MISSING VALUES CD (-1)
COMPUTE SPEC = SUMTN / CD
VARIABLE LABELS SENS 'SENSITIVITY OF TEST'
SPEC 'SPECIFICITY OF TEST'
COMMENT *** CALCULATE PREDICTED VALUE OF POSITIVE RESULT AND 
COMMENT *** PREDICTED VALUE OF NEGATIVE RESULT.
COMPUTE AB = SUMTP + SUMFP
DO IF (SUMTP = 0 AND SUMFP = 0)
COMPUTE AB = -1
END IF
MISSING VALUES AB (-1)
COMPUTE PVPR = SUMTP / AB
COMPUTE CD = SUMTN + SUMFN
DO IF (SUMTN = 0 AND SUMFN = 0)
COMPUTE CD = -1
END IF
MISSING VALUES CD (-1)
COMPUTE PVNR = SUMTN / CD
VARIABLE LABELS PVPR 'PRED. VAL OF + RESULT'
PVNR 'PRED. VAL OF - RESULT'
COMPUTE PERCTP = (SUMTP/SUMNUM) * 100
COMPUTE PERCFP = (SUMFP/SUMNUM) * 100
COMPUTE PERCTN = (SUMTN/SUMNUM) * 100
COMPUTE PERCFN = (SUMFN/SUMNUM) * 100
LIST VARIABLES SUMNUM SUMTP PERCTP SUMFP PERCFP SUMTN 
PERCTN SUMFN PERCFN SENS SPEC PVPR PVNR
FINISH
Programmes 7-42: (contd.)
The indications for a second scan were as shown in table 
(8). By far the commonest indication was the clinical 
suspicion that the fetus was growth retarded (585 
pregnancies, or 26.8%)
Table 8: Indications for referral for the second scan
Indication No. %
Clinical suspicion of IUGR 585 26.8
Previous history of IUGR 182 8.3
Hypertension 335 15.4
Diabetes 23 1.1
Antepartum haemorrhage/Abdominal pain 266 12.2
Miscellaneous 740 33.9
Total 2180 100.0
Data analysis was performed using the SPSSX package. The
predictive ability of the different parameters was
assessed by calculating the sensitivity, (i.e. the
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probability of obtaining an abnormal test result in babies 
eventually having an abnormal birthweight), specificity, 
(i.e. the probability of obtaining a normal test result in 
babies eventually having a normal birthweight) and 
predictive value of a positive and negative tests (i.e. 
probability of being abnormal/normal if the test is 
positive/negative). A chi-square test was used to analyse 
the differences.
Similar calculations and methods were followed in a 
subgroup of women (group 2) selected by using programmes 
(25-33) from group 1 who delivered within one week of the 
second ultrasound examination. Furthermore, analysis was 
repeated on a subgroup of women (group 3) selected by 
using programmes (34-51) from group 1, who had undergone 
the second ultrasound examination at 35 weeks gestation.
With regard to AA, AC, AAFL and ACFL measurements, the 
efficacy was calculated by using programmes [(43-51),(52- 
60), (61-69) & (70-78)] in different subgroups of women
(group 4, 5, 6 & 7), who had undergone the second
examination at 34 weeks gestation and within two weeks, 
one week, and two days of delivery respectively. The size 
of the 'at risk1 group (%) selected by the test was found 
by dividing the 'true-positive' + 'false-positive' tests 
by the total number tested x 100.
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Programmes 43-78: 
Programmes 43-51:
Programme s 43-51: 
Programmes 52-60: 
Programmes 61-69: 
Programmes 70-78:
Same as programmes 7-15, for each week 
of gestation from 28 to 36, [at 35th 
week of gestation (group 3)].
Same as programmes 7-15, for each week 
of gestation [at 34th week (group 4)].
Same as programmes 43-51, for 14 days 
before delivery (group 5).
Same as programmes 43-51, for 7 days 
before delivery (group 6).
Same as programmes 43-51, for 2 days 
before delivery (group 7).
The following page shows programme 46 as an example of the 
programmes 43-78. This example relates to AA (group 3).
FILE HANDLE ALPHA / NAME = n:GOUA02.US85.SPFALLUM85"
FILE HANDLE BETA / NAME =n:GOUA13.US86.SPFALLUM86"
FILE HANDLE GAMMA / NAME =":GOUA07.US87.SPFALLUM87"
ADD FILES FILE =ALPHA / FILE =BETA / FILE =GAMMA 
SELECT IF TA GT 0
AND NOFETUSD EQ 1 AND US LE 200 AND (WKSM GT 27 AND WKSM LT 37)
(SELECTION REPEATED FOR 14 DAYS BEFOR DELIVERY "TIMEDIFF LE 14",
7 DAYS BEFOR DELIVERY "TIMEDIFF LE 7" OR 2 DAYS BEFOR.
DELIVERY "TIMEDIFF LE 2")
SORT CASES BY QMHNO WKSM
MATCH FILES FILE = */BY = QMHNO / FIRST= FST/LAST=IAST 
VARIABLE LABELS FST '1= FIRST RECORD FOR THIS PATIENT'
LAST '1= LAST RECORD FOR THIS PATIENT1'
SELECT IF FST = 1 
COMPUTE TACT2 = 0 
MISSING VALUES TACT2 (0)
DO IF (WKSM = 15 )
RECODE TA (LO THRU 70.1 = 5)
( 70.2 THRU 71.9 = 10)( 72.0 THRU HI = 11) INTO TACT2 
( 778.8 THRU 809.6 = 10)( 809.7 THRU HI = 11) INTO TACT2 
(PROCEDURE REPEATED FOR EACH WEEK, 15 THROU 43)
ELSE IF (WKSM = 43 )
RECODE TA (LO THRU 877.3 = 5)
( 877.4 THRU 877.4 = 10)( 877.5 THRU HI = 11) INTO TACT2
END IF
COMPUTE NUM = 1 
COMPUTE TP=0 
COMPUTE TN=0 
COMPUTE FP=0 
COMPUTE FN=0
DO IF (BWCT2 LE 10 AND TACT2 LE 10)
COMPUTE TP = 1 
END IF
DO IF (BWCT2 GT 10 AND TACT2 LE 10)
COMPUTE FP = 1 
END IF
DO IF (BWCT2 GT 10 AND TACT2 GT 10)
COMPUTE TN = 1 
END IF
DO IF (BWCT2 LE 10 AND TACT2 GT 10)
COMPUTE FN = 1 
END IF
SORT CASES BY WKSM
Programmes 43-78:
AGGREGATE OUTFILE = *
/ BREAK = WKSM / SUMNUM SUMTP SUMFP SUMTN SUMFN = SUM (NUM TP FP 113
FN )
COMMENT *** CALCULATE SENSITIVITY AND SPECIFICITY 
COMPUTE AB = SUMTP + SUMFN 
DO IF (SUMTP = 0 AND SUMFN = 0)
COMPUTE AB = -1 
END IF
MISSING VALUES AB (-1)
COMPUTE SENS = SUMTP / AB 
COMPUTE CD = SUMTN + SUMFP 
DO IF (SUMTN = 0 AND SUMFP = 0)
COMPUTE CD = -1 
END IF
MISSING VALUES CD (-1)
COMPUTE SPEC = SUMTN / CD
VARIABLE LABELS SENS 'SENSITIVITY OF TEST'
SPEC 'SPECIFICITY OF TEST'
COMMENT *** CALCULATE PREDICTED VALUE OF POSITIVE RESULT AND 
COMMENT *** PREDICTED VALUE OF NEGATIVE RESULT.
COMPUTE AB = SUMTP + SUMFP 
DO IF (SUMTP = 0 AND SUMFP = 0)
COMPUTE AB = -1 
END IF
MISSING VALUES AB (-1)
COMPUTE PVPR = SUMTP / AB 
COMPUTE CD = SUMTN + SUMFN 
DO IF (SUMTN = 0 AND SUMFN = 0)
COMPUTE CD = -1 
END IF
MISSING VALUES CD (-1)
COMPUTE PVNR = SUMTN / CD
VARIABLE LABELS PVPR 'PRED. VAL OF + RESULT'
PVNR 'PRED. VAL OF - RESULT'
COMPUTE PERCTP = (SUMTP/SUMNUM) * 100
COMPUTE PERCFP = (SUMFP/SUMNUM) * 100
COMPUTE PERCTN = (SUMTN/SUMNUM) * 100
COMPUTE PERCFN = (SUMFN/SUMNUM) * 100
LIST VARIABLES WKSM SUMNUM SUMTP PERCTP SUMFP PERCFP SUMTN 
PERCTN SUMFN PERCFN SENS SPEC PVPR PVNR
FINISH
Programmes 43-78: (contd.)
Furthermore, for AA, AAFL, FL, ACFL and AC measurements, 
the rate of 'false-negative1 (i.e. the percentage of an 
abnormal birthweight fetuses who are incorrectly detected 
by the test as having a normal birthweight) and 'false- 
positive' (i.e. the percentage of a normal birthweight 
fetuses who are incorrectly detected by the test as 
having an abnormal birthweight) was calculated and 
compared in a subgroup of women (group 2) between 28 and 
36 weeks of gestation by a single examination within one 
week of delivery.
To compare the overall performance of AA, AAFL, FL, ACFL 
and AC measurements, two statistical procedures were 
applied on the bases of two assumptions: (1) The 'Law of
Total Probability' was applied on the first assumption 
that 'false-negative' and 'false-positive' results are 
equally bad. (2) A variation of the first procedure was 
used to investigate the minimal average cost on the basis 
of a second assumption, namely that, in clinical terms, 
the cost of a 'false-negative' result is much higher than 
of a 'false-positive result. The cost of the 'false- 
negative' result was assumed to be more than 10 times that 
of the 'false-positive'.
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To deal with these situations Infants with birthweights 
less than the 10th centile were refered to as abnormal 
(A), and those equal and more than the 10th centile were 
refered to as normal (N). Ten per cent of all infants were 
(A), so the probability of a randomly selected infant 
being abnormal is p(A) = 0.10. Similarly, p(N) = 0.90.
Using these notations for the outcome of a predictive
procedure, the error probabilities are:
probability (false-negative) = P (PN|a ) 
probability (false-positive) = P (PA|n )
To deal with assumption (1), the overall probability of 
error (mistake), i.e the probability that an infant chosen 
at random from the population will be wrongly classified 
by any of the measurements (AA, AAFL, FL, ACFL & AC) was 
calculated by using the following equation:
P (mistake) = [ P(PN|A) x  P(A) ] + [ P(PA|N) x  P(N) ]
On the basis of assumption (2), that 'false-negative1
results are more serious than 'false-positive' results,
costs were assigned to each outcome, 
i.e. Cl = Cost of 'false-negative'
C2 = Cost of 'false-positive'
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To compare the performance of the different measurements 
the cost of a 'false-negative1 was assumed to be more 
than 10 times than that of 'false-positive, e.g. 11 times 
So Cl = 11 x C2
C2 = 1/11 Cl
C2 = 0.09 Cl
The average cost for each measurement was calculated by
applying the formula of the 'Minimal Average Cost'
procedure.
[ Cl x P(PN|A) x P(A) ] + [ C2 x P(PA|N) x  P(N) ]
= [ Cl x P(PN|A) x P(A) ] + [ 1/11 Cl x [ P(PA|N) x  P(N) ]
= Cl [ [ P(PN|a ) x P(A) ] + 1/11 [ P(PA|n ) x P(N) ] ]
4.2.2 Intrauterine growth retardation and perinatal 
mortality and fetal malformation
Applying programme (79) on the computerised ultrasound and 
perinatal data bases, a total of 1838 women were selected 
in this part of the study and divided in to two groups, 
The study group (group 1) comprised 919 consecutive women 
who delivered growth retarded infants. The results in 
these pregnancies were compared with a control group of 
919 women (group 2), delivered immediately subsequent to 
each study woman, whose infants were not growth retarded.
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FILE HANDLE R /NAME=":GOUVOl.LIB7.GROUPA"
FILE HANDLE A/NAME=1 : GOUVOl .LIB7 .GROUPB"
ADD FILES FILE = R/FILE= A 
SELECT IF NOFETUSD EQ 1
RECODE BWCT2 (LO THUR 10=1)(11 THRU HI=2) INTO GROPA 
CROSSTABS VARIABLES = GRPA (1,2) PNRW (0,1)
/TABLES = GRPA BY PNRW
STATISTICS 1
Programme 79: SPSSX programmes to calculate chi-square
test for cases ( group 1) and controls (group 2) (as 
defined on pp 86 & 87) with regard to perinatal mortality.
SELECT IF NOFETUSD EQ 1
RECODE BWCT2 (LO THRU 5=1)(6 THRU 10=2)(11 THRU HI=3) INTO 
GRPB
CROSSTABS VARIABLES = GRPB (1,2) PNRW (0,1)
/TABLES = GRPB BY PNRW
STATISTICS 1
Programme 80: SPSSX programmes to calculate chi-square
test for the study groups (group 3 & group 4) with regard 
to perinatal mortality.
SELECT IF NOFETUSD EQ 1
RECEDE BWCT2 (LO THRU 10=1)(11 THRU HI=2) INTO GRPA 
RECODE FADEL@A (1 THRU HI=1)(ELSE=COPY)
CROSSTABS VARIABLES = GRPA (1,2) FADEL0A (0,1)
/TABLES = GRPA BY FADEL@A
STATISTICS 1
Programme 81: Same as programme 79, with regard to
congenital malformation.
Women with multiple pregnancies were excluded. Infants 
were defined as growth retarded when the birthweight was 
below the 10th centile according to the Scottish birth 
weight for gestation nomogram (Forbes & Smalls, 1982). 
The study group (group 1) was divided into two subgroups, 
those of birthweight less than the 5th centile (group I), 
and those between the 5th and 9th centiles (group II).
The control group (group 2) was those of birthweight
centiles between 10th and 100th. Perinatal deaths were 
defined as stillbirths and deaths occurring in live born 
within 28 days of birth.
The study and control groups were compared in term of
incidence of perinatal deaths and congenital malformation.
Congenital malformed infants were classified as: (1)
neural tube defect (NTD); (2) abdominal wall defect (AWD); 
(3) urinary tract defect (UTD); (4) skeletal defect
(Skeletal D); (5) chromosome defect (Chromosome D); (6)
Rhesus disease (Rh/Ab); (7) cardiac defect (Cardiac D); 
(8) other (Other D).
The chi-square test was performed to analyse for 
differences.
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4.3 RESULTS
4.3.1 Evaluation of the various ultrasound measurements
Of the 2180 women in the study population group 1, 990
(45.4%) were primiparae and 1190 (54.5%) multiparae . The 
mean birthweight of the infants was 3.150 Kg. Three 
hundred and fifty (350) newborn infants weighed less than 
10th centile (16% prevalence).
Table 9 displays the diagnostic efficiency of single and 
combined ultrasonic measurements performed between 28 and 
36 weeks of gestation. From table 9A, it can be seen that 
of the single parameters abdominal measurements have the 
highest sensitivity, predictive value of positive test and 
predictive value of negative test with a comparable 
specificity to the other parameters. Sensitivity was 
equal for AA and AC measurements, but lower with BPD and 
FL and considerably lower with HA and HC. The result 
obtained by combining two parameters in various ways is 
shown in table 9A. The AAFL and ACFL measurements showed 
a higher sensitivity, (36%) and (34%) respectively. 
Overall, the sensitivity of the AAFL measurement was the 
highest, and the difference between the number of growth 
retarded fetuses detected by AAFL and FL was statistically 
significant. (Chi-square = 6.55; p<0.02). The specificity
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was high and similar for all measurements single or 
combined. The predictive values of negative tests were 
also high and almost the same for all measurements.
Substantial improvement in the sensitivity and the 
predictive value of a positive test for all parameters was 
seen when the scan was performed one week before delivery 
(group 2), (Table 9B). The differences between the number 
of growth retarded fetuses detected correctly by AAFL and 
FL was statistically significant,(chi-square = 4.42;
p<0.05) and that between AA and FL was significant, (chi- 
square « 4.24; p<0.05).
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Table 9: Detection of IUGR by various methods
A. Ability to detect IUGR by single examination between 28 
and 36 weeks of gestation
Para­
meter
No. Sensi­
tivity
%
Speci­
ficity
%
Predictive 
value of a 
(+ve) test 
%
Predictive 
value of a 
(-ve) test 
%
At risk 
group
%
BPD 1234 21 95 44 87 7.5
FL 1074 20 93 36 86 8.8
HA 1229 24 93 39 87 9.6
HC 1260 27 94 44 87 9.7
AA 2137 29 95 52 89 8.0
AC 2150 29 96 52 89 8.0
LV 1501 13 92 22 86 8.9
AAFL 1050 36 95 57 89 9.8
ACFL 1062 34 95 58 88 9.0
B. Ability to detect IUGR when scan performed between 28 and 
36 weeks by a single ultrasound examination within one week 
of delivery
Para- No. Sensi­ Speci­ Predictive Predictive At risk
meter tivity ficity value of a 
(+ve) test
value of a 
(-ve) test
group
% % % % o
22.8
21.3 
23.5 
20.0
28.3
30.1 
28.8 
41.7
43.2
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BPD 79 56 87 56 87
FL 75 28 81 31 78
HA 81 45 85 53 81
HC 185 46 89 61 81
AA 173 81 85 59 94
AC 175 86 84 58 96
LV 125 38 74 28 82
AAFL 72 94 76 57 98
ACFL 74 89 71 50 95
A similar trend was seen when those women with scans that 
were performed at 35 weeks of gestation (group 3) were 
considered (Table 10). The sensitivity for AAFL, ACFL, AA 
and AC was the highest (47%), (42%), (39%) and (34%)
respectively, whereas BPD, FL and LV gave the lowest 
(19%), (17%) and (14%) respectively, the differences were
statistically significant for AAFL and LV. (Chi-square = 
3.62; p<0.05).
Specificity was similar for all parameters. The predictive 
value of a positive test was higher for AAFL, ACFL, AA and 
AC, 82%, 80%, 79% and 72% respectively, and lowest for FL
and LV, (33) and (25) respectively. The difference was 
statistically significant between AAFL and LV, (chi-square 
= 2.84; p<0.05) . the values for HC and HA were in
between.
The predictive value for a negative test was greater than 
81% for all ultrasound variables.
The four parameters AA, AC, AAFL and ACFL, were compared 
in those patients (group 4, 5, 6 & 7) whose scans were
performed at 34 weeks of gestation, within two weeks, 
within one week and within two days of delivery 
respectively (Table 11A, B, C & D) • In this comparison, 
AAFL and ACFL showed equally good results. Also, it was
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apparent that the sensitivity and the predictive values of 
positive test for all the measurements rose steadily with 
the rise in the percentage of 'at risk1 group, for example 
the sensitivity for AAFL rose from 44% to 100% when the 
percentage of ’at risk1 group rose from 10.9% to 66%.
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Table 10: Efficiency of various measurements in predicting 
IUGR at 35 weeks of gestation
Para­
meter
No. Sensi­
tivity
%
Speci­
ficity
%
Predictive 
Value of a 
(+ve) Test 
%
Predictive 
Value of a 
(-ve) Test 
%
BPD 127 19 97 63 82
FL 101 17 93 33 84
HA 122 25 93 50 81
HC 124 26 92 47 82
AA 246 39 98 79 90
AC 249 34 98 72 89
LV 183 14 92 25 85
AALF 99 47 97 82 89
ACFL 102 42 98 80 88
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Table 11: Detection of IUGR by AA, AC, AAFL & ACFL
measurements
A. Ability to detect IUGR by single ultrasound examination
at 34 weeks of gestation
Para­ No. Sensi­ Speci­ Predictive Predictive At risk
meter tivity ficity value of a value of a group
(+ve) test (-ve) test
% % % % o*o
AA 272 36 97 62 91 8.5
AC 276 35 95 54 90 8.7
AAFL 129 44 97 82 89 10.9
ACFL 130 42 95 62 91 10.0
B. Ability to detect IUGR when scan performed at 34 weeks
of
two
gestation by a single ultrasound examination 
weeks of delivery
within
AA 41 73 87 67 90 29.3
AC 41 91 87 71 96 34.1
AAFL 18 86 82 75 90 44.4
ACFL 18 100 73 70 100 55.6
C. Ability to detect IUGR when scan performed at 34 weeks
of gestation by a single ultrasound examination 
one week of delivery
within
AA 27 88 84 70 94 37.0
AC 27 100 74 62 100 48.1
AAFL 13 100 71 75 100 61.5
ACFL 13 100 57 67 100 69.2
D. Ability to detect IUGR when scan performed at 34 weeks
of
two
gestation by a single ultrasound examination 
days of delivery
within
AA 14 100 70 57 100 59.0
AC 14 100 60 50 100 57.1
AAFL 5 100 67 67 100 66.0
ACFL 5 100 33 50 100 80.0
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Table 12: Comparison of AA, AAFL, FL, ACFL & AC in 
detection of IUGR between 28 and 36 week of gestation by 
a single examination within one week of delivery
Parameter Detection of False- False-
growth retarded negative positive
fetuses
% % %
AA 81 19.0 8.5
AAFL 94 5.5 24.0
FL 28 72.0 19.0
ACFL 89 11.0 29.0
AC 86 14.0 16.0
Table 12 gives the results for AA, AAFL, FL, ACFL & AC
measurements between 28 and 36 weeks of gestation. The
FL measurements were inefficient since they identified 
only 28% of growth retarded fetuses. In contrast, the 
combination of AC or AA with FL correctly identified 86% 
and 81% of cases respectively.
Though the 'false-negative' rate obtained with FL was 72%
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and that with AA was 19%, the product of these two 
measurements AAFL gave a 'false-negative' rate of only 
5.5% (Table 12). Also the product ACFL gave a 'false- 
negative' rate of 11% which is less than FL and AC which 
were 72% and 14% respectively. Overall, AAFL was the 
most efficient combined parameter (Table 12).
To compare the overall performance of AA, AAFL, FL, ACFL 
and AC measurements, the 'Law of Total Probability' was 
applied on the basis of the first assumption that 'false- 
negative' and 'false-positive' results are equally bad 
(page 85). The formula of the 'Minimal Average Cost' 
procedure (page 86) was applied on the second assumption 
that the cost of a 'false-negative' result was more than 
10 times higher than that of a 'false-positive' result, 
e.g. 11 times. One example of these applications as used 
on the figures related to AA measurements in table 12 
(page 95) generated the following results:-
0.915
0.90 W
\).085 PA*
0.190 PN*
0.10 A
0.810 PA
* mistakes
Assumption (1)
If Cl * C2
P(mistake) = [P(PN|A) x  P(A)] + [P(PA|n) x  P(N)]
= [0.190 x 0.10] + [0.085 x 0.90]
0.0190 + 0.0765
0.0955
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Assumption (2)
If Cl = 11 x C2
[Cl x P(PN|A) x P(A)] + [C2 x P(PA|N) x  P(N)]
So average cost = Cl [0.0190 + 0.0765/11]
= Cl [0.0190 + 0.00695]
= Cl x 0.026
Table 13 shows the probability of mistake for AA, AAFL, 
FL, ACFL & AC measurements. On the basis of assumption 
that ,in clinical term, the 'false-negative' and 'false- 
positive' results are equally bad, the AA was the best 
measurement since it gives clearly the lowest probability 
of mistake (0.0955). While on the assumption that, in 
clinical terms, the cost of 'false-negative' result is 
much higher than the 'false-positive' result and on the 
assumption that the cost of the 'false-negative' is more 
than 11 times the average cost of AAFL measurement was 
0.025 x Cl (Table 14).
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Table 13: Summary of the probabilities of mistake for 
AA, AAFL, FL, ACFL & AC parameters
Parameters P(mistake)
AA 0.0955
AAFL 0.2215
FL 0.2430
ACFL 0.2720
AC 0.1580
Table 14: Summary of 
ACFL Sc AC
the average cost for AA, AAFL, FL, 
parameters
Parameters Average cost
AA 0.026 X Cl
AAFL 0.025 X Cl
FL 0.087 X Cl
ACFL 0.034 X Cl
AC 0.027 X Cl
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4.3.2 Intrauterine growth retardation and perinatal 
mortality and fetal malformation
Perinatal mortality
Table 15 shows that the perinatal mortality rate
associated with fetal growth retardation in the study
group was 3.9% compared with 0.3% in the control group. 
The difference was statistically significant (chi-square =
26.82; p = 0.0000)
Within the study group, the perinatal mortality rate for 
infants of birthweight less than the 5th centile (group 1) 
was 6.4% while that for those whose birthweight between 
5th and 9th centile (group II) was 1.7%, and the
difference was statistically significant (chi-square test
= 12.39; p = 0.0004), (Table 16).
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Table 15: Two-way table of alive versus dead fetuses for 
study group (group 1) versus control group 
(group 2)
Group
Birthweight
centile Alive Dead Total
Study 
(group 1) 0 - 9 883 (96.1%) 36 (3.9%) 919 (50%)
Control 
(group 2) 10 -100 916 (99.7%) 3 (0.3%) 919 (50%)
Total 1799 39 1838
Chi-square = 26.82 
DF = 1
p = 0.0000 (significant)
NB - Twenty-one congenitally malformed fetuses are 
included in the study and control groups.
Table 16: Two-way table of alive versus dead fetuses for 
study group (group I) versus study group 
(group II)
Group
Birthweight
centile Alive Dead Total
Study 
(group I) 0 - 4 410 (93.6%) 28 (6.4%) 438 (47.7%)
Study 
(group II 5 - 9 473 (98.3%) 8 (1.7%) 481 (52.3%)
Total 883 36 919
Chi-square = 12.39 
DF = 1
p = 0.0004 (significant)
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/
Fetal malformation
There was a significant difference between the incidence 
of fetal malformation in the study and the control group 
(chi-square = 12.33; p = 0.0002) (Table 17).
Table 18 shows the distribution in fetal malformation 
categories for study and control group. It was obvious 
that the numbers of cases of different types of fetal 
malformation were higher in the study group.
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Table 17: Two-way table of congenitally malformed versus 
normal fetuses for study group (group 1) 
versus control group (group 2)
Group
Birthweight No fetal 
centile malformation
Fetal
malformation Total
Study 
(group 1) 0 - 9 900 (97.9%) 19 (2.0%) 919 (50%)
Control 
(group 2) 10 -100 917 (99.8%) 2 (0.2%) 919 (50%)
Total
Chi-square
DF
P
= 12.33 
= 1
= 0.0004
1817 
(significant)
21 1838
Table 18: Distribution in fetal malformation categories 
for study group (group 1) and control group 
(group 2)
Fetal Study Control
malformation (group 1) (group 2)
n=919 n=919
Neural Tube Defect 1 0
Abdominal Wall Defect 4 0
Urinary Tract Defect 1 0
Skeletal Defect 0 1
Chromosomal Defect 6 0
Rhesus 1 0
Cardiac Defect 1 0
Others 5 1
Total 19 2
(19/919=2.07%) (2/919=0.22%)
/
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4.4 Discussion
4.4.1 Evaluation of various ultrasound measurements
The development of accurate ultrasonographic method for 
the antenatal detection of IUGR remains a major concern. 
Several studies assessing the effectiveness of various 
ultrasonic measurements have been published. Direct 
comparison with these studies is difficult as demonstrated 
by Deter and associates (1982). Studies vary in their 
definition of IUGR, the criteria used in the postnatal 
identification of IUGR infants, the cut-off point of the 
ultrasound measurement values and the dating method 
employed. Published normal birthweight distributions also 
vary as they are dependent on genetic, environmental, and 
social factors, as well as statistical handling. 
Interstudy comparisons are also made difficult by the 
lack of reporting results with all standard statistical 
parameters, e.g. the predictive value of a positive test 
may be given, but without the sensitivity. The sensitivity 
and true positive rates are also affected by the nature of 
the study population, whether it is a small group of 
intensively studied patients at a high risk or a screening 
test for a large patient population. In this study we 
determined the sensitivity, specificity, and predictive 
values of positive and negative tests, when groups of the
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QMH obstetric population and subgroups of 'at risk1 
patients were considered.
In contrast to the previous studies which had the 
confounding factor of using only menstrual dating, in this 
study all patients had an estimation of gestational age 
made by ultrasound by 20 weeks gestation followed by a 
second examination at 28 to 36 weeks. This approach, in 
conformity with other investigators (Neilson et al, 1980; 
Neilson et al 1984) gave a unique opportunity to remove 
the effect of uncertain gestational age from the study.
This study showed that head measurements were generally 
less efficient than the trunk measurements, the poorest 
sensitivity values being for BPD (21%). This finding is 
consistent with previous investigations by Warsof and 
associates (1986) who reported detection rates of 25% for 
a single BPD determination. Although previous reports by 
Queenan and associates (1976), Sabbagha (1978), Neilson 
and associates (1980), Kurjak and associates (1980), gave 
detection rates ranging from (50-60%), still these results 
were disappointing. Similarly, in this study, HA and HC 
measurements were inefficient since their detection rates 
were only 24-27%. Because the fetal HC has a close 
relationship to brain weight (Epstein & Epstein, 1978) and 
is a more shape-independent measurement than the BPD
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(Hadlock et al, 1983), it should, theoretically, set a 
better standard of head size which might explain why HC 
had a higher detection rate than HA and BPD. The common 
explanation of the lower detection rates of head 
measurements is that of brain-sparing effect in many cases 
of IUGR. In such cases, brain weight is relatively less 
diminished than liver weight where hepatic glycogen stores 
and Liver mass are severely reduced (Gruenwald, 1974; 
Evans et al, 1983).
Our results showed that AC and AA, when used singly, had 
high detection rates (86% and 81%, respectively) and the 
•false-negative' rates were considerably lower (14% and 
19%, respectively). This finding agrees with that of 
Neilson and associates (1980) who reported a detection 
rate for SGA fetuses of 83% with AC and (81%) with AA, and 
the 'false negative' rates were 17% and 19%, respectively.
Other investigators (Varma et al, 1979; Neilson et al, 
1984) studied the efficiency of AA in an 'at risk group' 
and the sensitivity was 80% and 91% respectively. Our 
result was comparable to that at 81%.
The effect of IUGR on the sonographic growth profile of 
the neonate depends on the time of initial insult and the 
duration and degree of the insult (Villar & Belizan,
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1982). Fetuses that are affected in the first trimester 
of pregnancy (chromosomal abnormality, infection) are 
symmetrically small throughout gestation with weight, 
length and head circumference below the 10th centiles. 
If the insult occurs late in the second trimester of 
pregnancy, the first organ to be affected is the fetal 
liver, while there is a relative sparing of the fetal head 
size and length (asymmetrical growth retardation)(Villar & 
Belizan, 1982). It is this period of time when the 
ultrasound findings are compatible with the decreased 
fetal AA and AC, therefore abnormal AA and AC.
In the present study, FL measurement was the least 
accurate of all variables. The sensitivity was 28% and 
the 'false-negative' rate was 72%. Similarly, Woo and 
associates (1985) could not detect any pattern of growth 
retardation in the FL. Though Gregory and associates 
(1982) found that symmetrical growth retardation could be 
identified by shortened FL, they believed that the ability 
to detect IUGR should be improved with a three- 
dimensional image of the fetus with the use of FL and AC.
In this study, the addition of the FL measurement to that 
of the AC or AA improved the detection rate and decreased 
the 'false-negative' rates. The 'false-negative' rate 
obtained with FL alone was 72% and that obtained with AA
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alone was 19%, while the combination of FL and AA gave a 
'false-negative' rate of only 5.5%. Similarly, the 
combination of FL and AC gave a 'false-negative' rate of 
11% while that obtained with AC alone was 14%. The most 
likely explanations is that, the growth of the fetal 
abdomen is the first to be impaired in some cases of IUGR. 
Besides, in utero the AC or AA is known to be the factor 
most closely related to fetal weight (Warsof et al, 1977; 
Woo et al, 1984), whereas the fetal long bones (femur) are 
known to correlate with the length of the fetus (O'Brien & 
Queenan, 1981) and closely related to the fetal crown-heel 
length (Hadlock et al, 1984). Therefore, the combination 
between the FL and AC or AA may provide better 
assessment of fetal size.
Several investigators evaluated the usefulness of the 
relationship between the FL and BPD in utero and showed 
that a high detection rate for growth retarded fetuses by 
the FL/BPD ratio was possible ( Waldimiroff et al, 1978; 
Varma et al, 1979; Wittman et al, 1979; Neilson et al, 
1980; Hohler & Quetel, 1981; Woo et al, 1985). In this 
study, trunk measurements were added to that of FL because 
they had an added advantage of being more affected than 
head measurement by growth retardation. Moreover, BPD is 
subject to head shape variation (e.g. dolichocephaly, 
brachycephaly) in utero, both as a variant of normal
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development and as a result of molding, or rarely, 
premature closure of sutures (Hadlock et al, 1981; Kasby & 
Poll, 1982; Wolfson et al, 1983) and fetal position (e.g. 
breech presentation, transverse lie), which could result 
in falsely high or low values when evaluating FL against 
BPD.
The AAFL and AA were equally good as they, respectively, 
picked out 94% and 81% of growth retarded fetuses of a 
population where the prevalence of the birthweight less 
than 10th centile was 16%. However a 24% of 'false- 
positive' rate for AAFL should not be ignored. In 
general, a procedure that gives a low 'false-negative' 
rate will give a high 'false-positive' rate and vice 
versa. Because 'false-negative' results are of greater 
significance than 'false-positive' results, i.e. the 
'false-negative is more costly than the 'false-positive', 
AAFL had a better performance, since it gave the lowest 
average cost. Also it was a more useful index than the 
ACFL, which was associated with a slightly higher 'false- 
negative' and 'false-positive' rates.
In this study, the sensitivity of LV of less than 10th 
centile (i.e. ranging from 4.4-4.6 cm from 28 to 36 weeks 
of gestation) was suboptimal at 38%. This was slightly 
higher than the previous reports. Philipson and
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associates (1983), Chamberlain and associates (1984) and 
Divon and associates (1986) showed that the sensitivity of 
LV of less or equal to 2 cm for identification of growth 
retarded fetus was 15.5%, 13% and 11% respectively. This 
difference may be accounted for, in part, by the
difference in the criteria for normal and abnormal LV, for
the cut-off value of less than 10th centile was used in
this study which may have attributed to a slightly higher 
sensitivity.
The predictive accuracy of a test is determined in part by 
the interval between scan and delivery. The greater the 
time interval the more chance that a growth abnormality 
could develop after the scan or that catch-up growth would 
occur by appropriate therapeutic intervention. This is 
seen clearly in improved accuracy in table 11A, B, C & D. 
On the other hand, the clinical usefulness of the
information in providing early warning of IUGR decreases 
as pregnancy advances. As obstetric events frequently 
cannot be predicted, it usually is difficult to control 
this time interval. Nevertheless, scanning at 34 weeks of 
gestation with high rates of sensitivity and specificity 
would compromise between the efficiency of the test and 
the clinical usefulness of the information provided.
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4.4.2 Intrauterine growth retardation and perinatal 
mortality and morbidity
Intrauterine growth retardation is recognised as a cause 
of significant perinatal morbidity and mortality. The 
present study, in conformity with previous investigations 
(Scott & Usher, 1966; Low & Galbraith, 1974; Jones et al, 
1977; Mcllwaine et al, 1979; Dobson et al, 1981; Forbes et 
al, 1982) showed that fetal growth retardation had a 
significant positive association with perinatal mortality 
and congenital malformation. It also showed that fetuses 
of birthweight less than the 5th centile for gestational 
age were at greater risk of perinatal death than those 
whose birthweight was between the 5th and 9th centiles. 
This result is in agreement with that of Dobson and 
associates (1981).
Previous reports indicated a close association between 
intrauterine growth retardation and fetal malformation 
(Scott & Usher, 1966; Dobson et al, 1981). This 
association was confirmed in this study. Many factors 
contribute to the association between IUGR and perinatal 
morbidity and mortality. Perinatal asphyxia is the most 
serious clinical complication of infants with IUGR (Scott 
Sc Usher, 1966). These infants are prone to develop 
intrauterine asphyxia and are at increased risk in the
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neonatal period from hypothermia (Burnard & Cross, 1958), 
hypoglycaemia (Lubchenco & Bard, 1971), hypocalcemia, 
polycythemia (Lugo & Cassady, 1971; Tsang et al, 1974) . 
Furthermore, babies who survive the neonatal period, are 
susceptible to higher incidences of subsequent 
neurological and behavioral disturbances, such as cerebral 
palsy, convulsion, mental retardation, and educational 
subnormality (Fitzhardinge & Steven, 1972; Fancourt et al, 
1976)
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4.5 Conclusions and Recommendations
In obstetrics today, IUGR can be diagnosed in almost all 
cases by ultrasound. This study demonstrates that head 
measurements (BPD, HA, HC) are poor predictors of the 
growth retarded fetus due to the brain-sparing effect 
present in many cases of IUGR. The abdominal measurements 
(AA, AC) are more sensitive guide to IUGR because reduced 
liver size is an early feature of IUGR.
The sensitivity of LV measurement, within one week of 
delivery, of less than 10th centile (range: 4.4-4.6 cm
from 28 to 36 weeks of gestation) was suboptimal. 
Consequently, LV measurement does not appear to be useful, 
on its own, in the detection of growth retarded fetus.
It is interesting that the combination of FL measurement 
with that of abdomen has markedly improved the diagnostic 
accuracy over that of single measurement of FL, AA and AC. 
This indicates again that the growth of the fetal abdomen 
is the first to be impaired. It also supports the 
hypothesis that a combination of length and cross-section 
provides a better assessment of fetal size.
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In conclusion, the combination of AA with FL is the most 
predictive measurement of IUGR as it has the highest 
sensitivity, specificity and predictive value of positive 
and negative test rates, and the lowest 'false-negative' 
rate. Because 'false-negative' results are of greater 
significance than 'false-positive' results, the AAFL 
measurement is a more useful indicator than the AA as it 
gives the lowest average cost. Despite a 'false-positive' 
rate of 24%, the AAFL measurement is still potentially 
useful in the management of a high risk pregnancies. It 
may be used as part of a standard obstetric ultrasound 
examination for the assessment of fetal growth in the 
second and third trimesters. Furthermore, calculation of 
the product of AA and FL by a single examination in mid 
third trimester is practically quick and simple. Combined 
with accurate ultrasound dating of gestational age early 
in pregnancy, high sensitivity, and predictive value of 
negative test, it would be potentially suitable as a 
screening procedure for the detection of IUGR. Such 
procedure would accommodate itself well into the 
philosophy of antenatal care that risk is better assessed 
by investigation of the individual fetus than by 
epidemiological considerations (BMJ Editorial, 1978).
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This study shows that fetal growth retardation has a 
significant positive association with the perinatal 
mortality and fetal malformation. In particular, infants 
of birthweight below the 5th centile are at a greater risk 
of perinatal mortality. To reduce the existing mortality 
and morbidity associated with the growth retarded fetus, 
an early antenatal diagnosis of impaired fetal growth is 
of paramount importance for appropriate timed delivery 
and intensive intrapartum and neonatal care.
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